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ABSTRACT
The hypothesis that dietary fat can influence glucose tolerance and insulin 
sensitivity adversely or beneficially was tested in a series of experiments in rats fed 
variable amounts and types of fat for periods up to 6 weeks. Studies included the 
development of an intravenous glucose tolerance test (ivGTT) and measurement of 
weight gain, food intake, organ weight including adipose tissue in terms of epididymal, 
suprarenal and mesenteric fat pads, and in some studies membrane fatty acid profile in 
liver and red blood cells. Insulin sensitivity was measured by relating changes in glucose 
concentration to measured insulin levels. A crude measure of the p cell response to 
glucose, the insulinogenic index, was evaluated from the relationship between insulin 
levels and glucose concentrations.
After an initial series of pilot studies with 20% (w/w) com oil, olive oil, and fish 
oil/olive oil diets to establish the methods, glucose tolerance and insulin responses and 
action were measured in three studies. In experiment I 20% (w/w) com oil, olive oil, 
butter oil and fish oil/olive oil (1:4) diets were fed for 5 weeks. Although there were no 
significant differences (p=0.05) in food intake rats fed olive oil and butter were heavier 
with larger fat pads and less glucose tolerant than those fed com oil or fish oil/olive oil, 
although fasting glycaemia did not vary with diet. Insulin levels measured by ELISA 
were judged unreliable in this study. Membrane fatty acids reflected the dietary fatty acid 
composition in terms of amounts of SEA, MUFA and n-6 and n-3 PUFAs.
In a second study the fats were fed com-oil, olive oil, butter or fish oil/olive oil 
(1:1), at 10% (w/w) for 5 weeks. In this case there were no sustained diet effects on 
bodyweight or food intake but fat pad size was again increased in the olive oil and butter 
groups. Glucose tolerance was only impaired in the butter group which exhibited a 
hyperinsulinaemia and impaired insulin sensitivity assessed by a reliable assay.
To resolve the discrepant responses to the MUFA diet in a third experiment 20% 
(w/w) diets of com-oil, olive oil, butter, fish oil/olive oil (1:1), or fish oil/butter (1:1) 
were fed for 5 weeks with a chow-fed control group, all diets fed at a fixed intake close 
to the maximum ad lib level. Rats fed olive oil and butter were heavier with larger fat 
pads than all other groups.. Compared with the chow fed group glucose tolerance was 
only impaired by butter which also resulted in an hyperinsulinaemia and impaired insulin 
sensitivity not observed in the fish-oil butter diet. Membrane fatty acid profiles in hepatic 
and red-cells indicated that glucose tolerance was not influenced by the n6-n3 PUFA 
ratio with only total SFA reflecting glucose tolerance.
These results indicate that in this rat model although both SFA and MUFA high 
fat diets increase fatness compared with n6 or n3 PUFA diets only SFA impairs glucose 
tolerance or insulin sensitivity, effects not observed when SFA is fed with fish oil. 
MUFA or PUFA diets maintain glucose tolerance although only PUFA diets prevent 
increased fatness.
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CHAPTER I
INTRODUCTION
Epidemiological, clinical and experimental studies have confirmed that diet 
plays a critieal role in the normal physical and mental development. Prevalence of 
'so called' diseases of civilization in developed countries and their relatively lesser 
occurrence in developing countries points towards the influence of diets in etiology 
of these diseases.
Diabetes mellitus (DM) is one sueh disease and one of the most common 
maladies encountered in man. The incidence of DM has increased by several folds in 
the U.S. population since sixties. It is the third ranking cause of death in the 
developed world (Friedman, 1980). Diabetes is a disorder of glucose intolerance 
with most chronieity leading to severe complications including cardiovascular 
disorders, microvascular disease and renal failure (Wiersma et al, 1993). The 
pathophysiology of diabetes mellitus is complex, where environmental factors 
interact in genetically predisposed individuals and lead to hyperglycemia, an 
expression of DM. The most recognized environmental and socio-demographic 
factors affecting DM include age, obesity, visceral fat distribution, physical inactivity 
and living in urban communities (Persson et al, 1994).
National Diabetes Data Group classified two diabetes into two main types: 
insulin-dependent diabetes mellitus (IDDM or Type I) and non-insulin dependent 
diabetes millitus (NIDDM or Type II) (National Diabetes Group (1979). NIDDM 
usually manifests in adulthood around age 40 or later. About 90% of patients with 
NIDDM are obese and may not display the classic symptoms of diabetes (Rifkin & 
Porte, 1990). They may initially be hyposecretors, normal secretors, or 
hypersecretors of insulin. However, the insulin does not appear to be effective in the 
transport of glucose into cells. Inactive receptors, desensitized receptors, or 
inadequate insulin action may produce this condition. NIDDM gradually increases, 
family history is positively common, and obesity is more afeliated (Rifkin and Porte, 
1990).
Diet plays a crucial role in maintaining glycaemic control or improved 
glucose toleranee in NIDDM patients (National Diabetes Data Group, 1979). The 
other important role of diet therapy in this disorder is to reduce the risk of coronary 
heart disease. The other form of diabetes termed IDDM, requires exogenous insulin 
to compensate for the diminished insulin output by the p-cells of pancreas. However, 
it has been suggested that insulin-stimulated glucose uptake in both these forms of 
DM is affected as indicated by impaired glucose tolerance (Storlien et al, 1991). 
Severe insulin resistance has also been exhibited by subjects with normal glucose 
tolerance but higher insulin secretion tends to compensate for the insulin resistance. 
Whether these individuals go on to develop NIDDM ultimately will depend on the 
capacity of the pancreatic p-cells to maintain adequate insulin production (William, 
1994).
Experimental studies strongly suggest that both glucose tolerance as well as 
insulin sensitivity are influeneed by diet. Consumption of diets with polyunsaturated 
fat result in lower incidence of DM (Lardinois & Starich, 1991; Snowdown & 
Philllips, 1985). In contrast a positive correlation was found between consumption of 
diets high in saturated fat and glucose intolerance (West, 1978). Dietary fatty acid 
profile has been shown to affect insulin sensitivity in several human and animal 
studies (Storlien et al 1991; Borkman et al, 1993). Fatty acids in diet alter the lipid 
environment in membranes by replacing membrane fatty acids. The explanation for 
the differences in carbohydrate metabolism after consumption of varied fat quality 
could be related to this altered membrane lipid profile which affect insulin sensitivity. 
Membrane lipid environment may influence insulin receptor binding affinity and 
sensitivity, which are associated with alterations in responsiveness of cells to insulin 
(Gould et al, 1982; Sandra & Fyler, 1982).
The objectives of the present studies were to investigate the effect of dietary 
fats: com oil (n-6 Polyunsaturated fat), olive-oil (n-9 predominantly monounsaturated 
fat, butter oil (saturated fat with low n-6 precursors) and fish oil (n-3 polyunsaturated 
fat) on glucose tolerance and insulin sensitivity in normal adult rats.
LITERATURE REVIEW
Glucose Metabolism And Transport:
Glucose is an important metabolic substrate and is present in organisms in its 
simple, monomeric form (a-D-glucopyranose), and as a branched polymer of a- 
glucose, namely glycogen. The total amount of glucose in the body is small; it is 
unevenly distributed and virtually confined to the extra-eellular fluid (ECF) and liver 
cells. Under basal eonditions the concentration of glucose in interstitial fluid and 
plasma (Whether arterial, capillary or venous) are equal and reflects the size of the 
body glucose pool (Searle, 1976). Estimates of the glucose space in man vary from 
25-35% of total body volume. The glucose pool in the resting subjeet averages about 
15-20 g (83-110 mMol/L) and glucose turnover varies between 120-180 mg (0.66-1.0 
mMol/L) per minute which corresponds to about 170-260 g per day (Searle, 1976) of 
which between one half and one third is accounted for by the brain (Butterfield, 
1961).
The postprandial hyperglycemia is dependent upon the amount and form of 
carbohydrate ingested and on the amount of accompanying protein and fat (Gerich,
1993). In general, eomplex carbohydrates are absorbed more slowly than simple 
sugars, and protein and fat delay absorption; both of these factors reduce postprandial 
glucose excursions. After a carbohydrate meal, plasma glucose levels increase after 
15 minutes, glucose production is inhibited, and glucose utilization is enhanced. 
Plasma glucose, glucose production, and glucose utilization return to basal levels
after 180 minutes. These changes are associated with a parallel increase in plasma 
insulin and a decrease in plasma glucagon. The major tissues responsible for glucose 
removal after a earbohydrate meal are the liver, small intestine, brain, skeletal 
muscle, and adipose tissue (Gerich, 1993). Skeletal muscle and splanchnic tissues 
(liver, small intestine) each probably account for 30%, brain for 20%, and adipose 
tissue for 10% of glucose taken up. The uptake of glucose by skeletal muscle and 
adipose tissue is influenced by both plasma glucose and insulin levels, whereas the 
uptake of glucose by the brain is only influenced by plasma glucose levels. Adipose 
tissue lipolysis and lipid oxidation are suppressed after carbohydrate ingestion. Of 
the glucose taken up by tissues, 60% is used for replenishment of liver and muscle 
glycogen stores, 30% is oxidized, and 10% is released as lactate into the circulation 
for further uptake by the liver for indirect glycogen formation.
A family of proteins, the glucose transporters (Kahn and Flier, 1990) residing 
in the plasma membrane ean specifically and reversibly bind glucose molecules, and 
transfer them across plasma cell membranes in both directions. More than one 
species of glucose transporter is usually expressed in a tissue. Present knowledge in 
this rapidly evolving field indicates that only one type of glucose transporter (termed 
Glut 4) shows clear sensitivity to acute insulin stimulation in vivo. This transporter is 
abundantly expressed in the elassic insulin sensitive tissues viz., (adipocyte, 
brownfat, skeletal, heart and smooth muscle (DeFronzo and Fersannini, 1992). In 
contrast, in many mammalian cells, glucose enters by carrier-mediated facilitated 
diffusion which is not regulated by insulin. Two non-insulin-regulatable glucose
transporters (Glut 1 and Glut 3) have been identified in the blood-brain barrier and 
placenta (Kahn and Flier, 1990).
In adipose cells from normal, lean, growing male rats, the basal rate of 
glucose transport is relatively low and is enhanced 20-30 fold by 6.7 nM 
(lOOOpU/ml) insulin. The time course of redistribution of glucose transporters is 
slightly more rapid than that for glucose transport activity with tVi of 2.5 min and 
maximal stimulation in 6-8 min. Addition of antiinsulin antiserum also fully reverses 
the redistribution with the same tVi as the reversal of glucose transport activity 
(Kamieli et al, 1981).
Glucose taken up by muscle cells has two main fates: storage as glycogen or 
conversion to pyruvate. Pyruvate can then be converted to lactate, which is released 
into the circulation, or it can be oxidized to COj. The relative proportion of glucose 
that is metabolized in these different pathways varies between tissues and is 
dependent upon the hormonal environment and the presence of alternative substrates, 
for example, free fatty acids or ketone bodies. Thus, in the postabsorptive state there 
is no net storage of glucose, and all glucose taken up is either completely oxidized or 
converted to laetate whieh can be recycled back to the liver to be used for 
gluconeogenesis (Randle et al, 1988; Felig, 1973).
Glycogen
Glycogen Synthase
UDPG
G-l-P <
GLUT 4
Hexokinase
>► G-6-P>GlucoseGlucose
Glycolysis
Lactate ^Lactate Pyruvate
Pyruvate dehydrogenase
Acetyl-CoA
F ig  1:1 Schematic representation of the glucose metabolism in skeletal muscle. G - l - P ,
glucose-l-phosphate; G - 6 - P, glucose-6-phosphate; UDPG, uridine diphospate glucose 
(Girard, 1995).
Post-transporter glucose utilization can also change. Thus in vivo insulin- 
stimulated glucose utilization is reduced in older rats (12-months-old) as compared 
with younger (1.5 months-old) rats. A decrease in phosphofructokinase activity of 
muscle from older rats, suggests an age-related defect in insulin-stimulated glucose 
disposal (Narimiya et al, 1984). The activity of maternal acetyl-CoA carboxylase 
and ATP citrate lyase in white adipose tissue is very low during the suckling period 
and is increased at weaning on to a high (60%) carbohydrate diet (Issad et al.
7
1988). Homeostatic control is diminished in aging mammals and this includes the 
regulation of glucose metabolism. In humans, this is reflected by declining glucose 
tolerance with age (DeFronzo et al, 1979).
Exercise in fat rats reduces their muscle triacylglycerol levels which 
improves insulin-stimulated glucose metabolism in vivo (Storlien et al, 1991). 
Cold exposure (4°C) improved glucose tolerance, decreased body weight gain, 
increased brown adipose tissue mass and enhanced insulin sensitivity of peripheral 
tissues in rats fed a high-fat, low protein diet for 10-weeks (Vallerand et al, 1986).
Insulin Secretion And Action:
General Physiological Role:
Insulin accelerates the active transport of glucose (along with potassium 
and phosphate) through cell membranes; therefore it tends to decrease blood 
glucose (hypoglycemic effect) and to increase glucose utilization by the cells, 
either by catabolic or anabolic processes. Insulin stimulates the production of liver 
cell glucokinase; therefore it promotes liver glycogenosis, another effect that tends 
to lower blood glucose by inhibiting the liver cell phosphate (Denton and Tavare, 
1992). Insulin stimulates the rate of amino acid transfer into cells, so it promotes 
anabolism of proteins within the cells (Houslay, 1985); while the rate of fatty acid 
transfer into cells is increased promoting fat anabolism (lipogenesis) and inhibiting 
fat catabolism.
8
The fuels available for the energy requirements of the body can be derived 
from exogenous or endogenous sources. Glucose, free fatty acids, amino acids, 
lactate, and ketone bodies, all act as metabolic fuels, to a variable degree according 
to the nutritional state. In the postprandial state, the pool size of metabolic fuels in 
blood is expanded. Hypercaloremia is not desirable for the maintenance of normal 
metabolism, therefore, this hypercaloric state is rapidly restored to normocaloremia 
by the secretion of insulin.
There is enough evidence that insulin plays an essential role in the 
regulatory mechanisms which maintain energy metabolism in the whole body 
(DeFronzo & Fersannini, 1992). Regulatory mechanism of insulin receptors, 
including the balance between synthesis and degradation of receptors is another 
important role of insulin in receptor synthesis (Denton, 1986; Zick, 1989).
Studies with the epidermal growth factor and platelet-derived growth factor 
receptors have indicated that these tyrosine kinase receptors are associated with a 
number of proteins, including phospholipase C-gamma, phosphatidyl inositol 3- 
kinase and ras-GAP (Anderson et al 1990; Ullrich and Schlessinger, 1990; Cantley 
et al, 1991). These proteins are all phosphorylated on tyrosine and in the case of 
the first two proteins (Cantley et al, 1991; Nishibe et al, 1990), and it has been 
suggested that they form a ‘signaling complex’ which associates with the 
autophosphorylated form from the receptors, perhaps via a non-catalytic domain 
(known as the SHj-domain) shared by phospholipase C-gamma and phosphatidyl 
inositol 3-kinase (Anderson et al 1990). However, similar observations have only
been reported with the insulin receptor in the case of phosphatidyl inositol 3-kinase 
(Ruderman et al, 1990) but the physiological role of this enzyme is a not known 
(Cantley et al, 1991; Carpenter & Cantley, 1990).
Insulin Secretion:
Glucose is the principal regulator of islet P-cell function. It directly 
stimulates insulin release, and a raised concentration of glucose amplifies the 
insulinotropic actions of non-glucose nutrient fuels and secretagogues, such as 
enteroinsular hormones and neurotransmitters (Leahy, 1990; Rosetti et al 1990). 
The route of glucose administration, rate of gastric emptying, secretion of gut 
hormones, activation of autonomic nerves and the degree of p-cell insulin 
sensitivity will all influence the insulin response. Thus, although oral glucose 
tolerance tests provide a means to diagnose NIDDM, intravenous glucose 
represents a more valid and reliable means of assessing P-cell function (Turner & 
Matthews, 1984; Robertson, 1989; Leahy, 1990). Thus some NIDDM subjects 
may exhibit normal or moderately raised fasting insulin concentration and greater 
than normal insulin responses to orally administered glucose (Kahn & Porte, 
1990). However, the prevailing hyperglycaemia often stimulates basal insulin 
output to apparently normal or supernormal levels, particularly if obesity and 
insulin resistance are present. Nutrients other than glucose, particularly amino 
acids, are also capable of stimulating insulin release. Arginine appears to be the 
most potent amino acid stimulus of insulin secretion (Halter et al 1979).
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In addition to glucose and amino acids, many other signals such as gut 
hormones, stress hormones, and nutrients, affect insulin secretion by the p-cell and 
insulin itself may have an inhibitory feedback effect on p-cell insulin secretion 
(Liljenquist et al, 1978; Stagner et al, 1989). Many gastrointestinal peptides have 
been isolated from intestinal and nervous tissue which have the ability to stimulate 
insulin secretion, notably (Knuhtsen et al, 1987; Hermansen & Ahren, 1990).
Plasma 
Amino acid
Sympathetic 
Neurons and
Concentrations Circulating
Epinephrine
Plasma
Glucose
Concentration
Hormones from 
Gastrointestinal 
Tract
Parasympathetic
Neurons
Other
Hormones
B CELLS OF ISLETS
Insulin
F ig  1:2 Control of insulin secretion
The endocrine pancreas has a rich supply of catecholaminergic nerves, 
originating from the splanchnic trunk (Miller, 1981). Catecholamines, also reach 
the insulin-secreting p-cell via the circulation from the adrenal gland. Inhibition of 
insulin release by the adrenaline and noradrenaline catecholamines is mediated by 
the activation of a-adrenergic receptors (Schuit & Pipeleers, 1986), although both 
a lowering of cyclic AMP as well as reduction in [Ca^^] have also been suggested
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to account for its inhibitory effect (Yamazaki et al, 1982; Sussman et al, 1987). 
Other studies have suggested that a-adrenoceptor activation leads to inhibition of 
insulin release by a mechanism distal to those regulating P-cell cyclic-AMP 
production and [Ca2^] (Ullrich & Wollheim, 1984; 1988).
Insulin action on glucose transport:
The initial event in the action of insulin is its binding to an activation of a 
specific receptor protein in the plasma membrane of target tissues, the most 
important of which are liver, fat and muscle. There is a considerable degree of 
amplification involved between the binding of insulin to as few as 2000 insulin 
receptors on the plasma membrane of each fat or other cell, and the resulting 
regulation of the activity of many millions of target enzymes and other molecules 
within the cell, such as glucose transporters, glycogen synthase and acetyl-CoA 
carboxylase. The binding of insulin to its receptor results in the rapid translocation 
of glucose transporter proteins from an apparently intracellular membrane location 
to the plasma membrane (Cushman and Wardyala, 1980; Suzuki and Kono, 1980).
Kahn and Cushman (1985) produced a hypothetical model of insulin’s 
action on glucose transport (Fig 1:3). According to this model insulin binds to its 
receptor in the plasma, membrane (Step 1), generating a signal (Step 2) the nature 
of which is unknown. This results in the exocytic movement of membrane vesicles 
containing glucose transporters from an intracellular pool to the plasma membrane 
(Step 3) where they first bond (Step 4) and subsequently fuse (Step 5) exposing 
glucose transporters to the extracellular medium and increasing glucose transport
12
rate (Step 6). When insulin dissociates from its receptor due to either physiological 
events or experimental treatment of cells with antiinsulin antiserum or collagenase 
(Step 7) (Kono et al, 1982), the process is reversed. Glucose transporters which are 
present in the plasma membrane are then reintemalized by an endocytic process 
and translocated back to the intracellular pool (Step 8).
Dissociation
®  Transiocation
(S) TransportGlucose
Glucose
Transporters
(3) TransJocation
(g) Binding
' 0  Signal
Plasma
Membrane(3) Association
Intracellular
Pool
Fig 1:3 Hypothetical model of insulin’s action on glucose transport (Kahn and Cushman, 
1985).
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Impaired glucose tolerance and insulin action:
Impaired glucose tolerance (IGT) is not diabetes mellitus per se, but 
describes glucose tolerance outside the range normally found in young healthy 
adults. These subjects are at higher risk than the general population for the future 
development of diabetes, and IGT may represent a stage in the natural history of 
NIDDM: if followed up, 10-25% will develop NIDDM within 5-years (Sicree et al, 
1987; Saad et al 1988; Zimmet & King 1985). Epidemiological studies indicate 
that the prognosis of IGT is variable over 5-10 year periods around 30-40% of 
subjects will return to normal glucose tolerance, with a maximum of about 30% 
progressing to NIDDM (Zimmet & King , 1985). The likelihood of developing 
NIDDM is much higher in those at the upper end of the 7.8-11.1 mmol/L IGT 2-h 
plasma glucose range than it is at the lower end (Sicree et al, 1987). Subjects with 
IGT tend to be obese, and more often have a family history of NIDDM than 
similarly aged subjects with normal glucose tolerance (Harris, 1989). Individuals 
with continuing IGT do not develop significant microvascular (renal, neuropathic 
or retinal) complications but have increased prevalences of coronary heart and 
arterial disease associated with premature death, as compared with age-matched 
normal subjects. As a group, IGT subjects show increased frequencies of 
hypertension, hyperlipidaemia, obesity and fasting hyperinsulinaemia. Insulin 
resistance may underline the impaired glucose tolerance and possibly some of the 
associated abnormalities (Harris et al, 1987). Subjects with IGT, as indicated by 
longitudinal studies, show that those individuals with impaired glucose tolerance 
who are most likely to progress to NIDDM also display lower insulin levels,
14
indicative of P-cell decompensation (Knowler & Bennett, 1983; Sicree et al, 1987). 
Several studies have indicated that dietary restriction with even modest weight loss 
and increased exercise can achieve short-term improvement in glucose tolerance in 
subjects with IGT. The degree of resistance to insulin-stimulated glucose uptake 
in patients with IGT is comparable in magnitude to that found in patients with 
NIDDM (Reaven, 1988; Storlien et al, 1991).
Cross-sectional data from several populations including Caucasians suggest 
that the development of IGT and mild NIDDM is associated with decreased 
insulin action in vivo. The mechanism remains unknown, but may include 
decreasing insulin levels in certain cases and recent studies support the hypothesis 
that the prolonged, mild hyperglycemia of IGT may result in an acquired P-cell 
insensitivity to glucose stimulus (Bennett et al, 1992). The mean total islet volume 
may diminish to 50-60% of the mean normal value in NIDDM patients (Kloppel & 
Drenck, 1983), while the total volume of the pancreas in NIDDM is not 
significantly altered but fatty infiltration (Westermark & Wilander, 1978) and 
diffused fibrosis (Warren et al, 1966) are commonly found.
Peripheral vascular disease may cause intermittent claudication and 
gangrene, sometimes requiring amputations. Together with neuropathy, it is a 
major cause of the diabetic foot syndrome, a source of considerable morbidity and 
cost to the health services. Coronary artery disease, however, is the main scourge 
of NIDDM. Angina afflicts 17% or more of patient (Gill, 1986) and ultimately 
nearly 60% die from ischaemic heart disease (Marks & Krall, 1971). As with
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stroke, myocardial infarction is more common in diabetes (Rytter et al, 1985) and 
also carries a worse prognosis (Gwilt, 1984). Overall mortality from Ml in 
NIDDM is increased 2-3 fold and life expectance is reduced by 5-10 years 
compared with the general population (Panzram, 1987).
Epidemiological studies:
Diabetes mellitus and impaired glucose tolerance are spectrum of glucose 
intolerance. The pathophysiology of diabetes mellitus is complex, where, 
environmental factors interact in genetically predisposed individuals and lead to 
hyperglycemia, an expression of diabetes mellitus. The most recognized 
environmental and socio-demographic factors are: age, obesity, visceral fat 
distribution, physical inactivity and living in urban communities (Persson et al,
1994).
Most epidemiological studies reveal a significant positive correlation 
between serum triacylglycerol concentrations and CHD risk (Grundy & Denka,
1990). Lipoprotein lipase (LPL) activity is depressed in NIDDM and other insulin 
resistant states (Elliott & Vibarte, 1993). Epidemiological studies in non-obese 
healthy subjects found a strong correlation between the degree of insulin resistance 
and plasma triacylglycerol and VLDL, and a significant negative correlation with 
plasma post heparin LDL (Zavaroni, 1989).
Diabetes mellitus has variable degrees of prevalence in different parts of the 
world. There has been, however, a significant shift over the last 20 years, where 
the highest prevalence is found in the developing countries and certain ethnic
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minorities (King & Rowers, 1991). Such countries and communities have 
witnessed significant economical development. This has resulted in major 
urbanization with increasing income, manifested in adoption of western life style 
with respect to nutritional habits and physical inactivity. Saudi Arabia, a middle 
eastern country with estimated population of 13.2 million, 70% are less than 30 
years of age per the National Population Census, 1992. (National Population 
Census, 1992). Urban to rural population distribution is 62% to 32% and it has 
experienced very rapid economical development and the socio-cultural and 
nutritional changes. The prevalence of obesity is among the highest reported in the 
world (Al-Nuaim et al, 1997). Significant number of hospital beds are occupied by 
patients with cardiovascular disease, hypertension and diabetes mellitus (Al-Balla 
et al 1993).
Several studies on the prevalence of NIDDM were conducted in different 
regions of Saudi Arabia. Bacchus et al (1982) reported prevalence of 6% among 
male population of Riyadh city. Fatani et al (1987) reported prevalence of 3% - 
5% among population of the western region. Diabetes prevalence was reported to 
be 3.6% and 5.5% among male and female subjects of the Southern region 
respectively (Abu Zeid and Alkassab, 1982).
Diabetes mellitus is a chronic metabolic disease and major risk factor for 
coronary heart disease (Reaven, 1988). It is the leading cause for blindness and 
renal failure in the developed countries. Such complications are frequent 
occurrence among Saudi diabetic patients as well. Famuyiwa et al (1992) reviewed 
medical files of consecutive 1,000 Saudi diabetic patients in general hospital and
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the complication rates were 32%, 26%, 11.3% and 6.9% for retinopathy, 
hypertension, ischaemic heart disease and renal insufficiency, respectively.
EFFECT OF DIET ON GLUCOSE METABOLISM AND INSULIN 
SENSITIVITY
Carbohydrate:
Substantial scientific work has pointed out a constantly growing number of 
factors influencing the metabolic response to dietary carbohydrate. Increasing 
dietary carbohydrate content firom 40 to 61 percent of total caloric intake (with a 
commensurate reduction in fat intake) is associated with a fall in fasting and 
postprandial plasma glucose concentrations and glycosylated hemoglobin (9.6 to 
8.6 percent) in patients with NIDDM (Simpson et al, 1981). Dietary fiber has been 
shown to reduce significantly postprandial blood glucose and insulin levels in 
healthy (Jenkins et al, 1977) and diabetic individuals (Goulder et al, 1978). The 
importance of the nature of cabohydrate itself has also been stressed in several 
reports (Crapo, 1986). Simple carbohydrates like glucose, fiiictose and sucrose 
have totally different effects on glucose metabolism (Hassinger et al, 1981). Co­
ingestion of fat and protein may reduce carbohydrate induced hyperglycemia and 
enhance insulin release (Estrich et al, 1967). Dietary carbohydrate have been 
shown to have ability to enhance insulin sensitivity in several experimental studies. 
Insulin sensitivity improved by approximately 30% when dietary carbohydrate was 
increased from 43% to 75% of total calories in isocaloric diets (Kolterman et al, 
1979), whereas an increase in carbohydrate intake from 32% to 53% resulting in a
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20% improvement in yet another study (Beck-Nielsen et al, 1978). HC diets 
improves the carbohydrate economy by enhanced peripheral sensitivity to insulin 
(Fukagawa et al, 1990; Grimditch et al, 1988), lower fasting glucose (Villaume et 
al, 1984) and they also lower LDL cholesterol (Borkman et al, 1991) in diabetic 
patients as well as in normal subjects (Grundy, 1986). Disturbed carbohydrate 
metabolism is present in both patients with insulin-dependent-diabetes and non­
insulin dependent diabetes mellitus (Reaven et al, 1983; Liu et al, 1983). 
Hyperinsulinemia is a common finding in individuals with NIDDM (Coulston et 
al, 1987; Fontbonne et al, 1989), and there is evidence the hyperinsulinemia may 
play an important role in the development of coronary artery disease (CAD) 
(Fontbonne et al, 1989).
Although high carbohydrate diets are generally believed to increase insulin 
sensitivity (Brunzell et al, 1977), it has been shown by other workers that such 
diets resulted in increased daylong glucose and insulin concentrations and 
increased urinary glucose excretion. This appears to be a common finding in 
patients with diabetes (Anderson et al, 1980; Kiehm et al, 1976).
Kolterman et al (1979) reported an increase in insulin-stimulated glucose 
disposal rate after feeding diets containing 75% of total calories as carbohydrates, 
whereas Borkman et al (1991) failed to demonstrate any significant improvement 
in insulin-stimulator glucose uptake after diets containing 55% of calories as 
carbohydrate. In a similar study moderate increase in dietary polysaccharides 
resulted in hyperglycemia, hyperinsulinemia with little or no effect of glucose
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tolerance in NIDDM patients (Sestofl et al, 1985). However, it has been shown in 
other animal experiments that high carbohydrate diets improve glucose tolerance 
only in the animals which were able to increase their insulin secretion (Saekow and 
Olefsky, 1980).
Dietary fa t and membrane lipids:
Experimental studies have confirmed the role of dietary fat in modulating 
the membrane lipid composition. The altered lipid profile of membranes affects 
the membrane fluidity and permeability which in turn seems to influence the 
metabolic activity at the cellular level (Luo et al, 1996). The fatty acids in 
membranes are rapidly turned over and the rate of incorporation is probably 
determined by the fatty acid profile of the diet and the individual fatty acid 
characteristics (Palombo et al, 1993).
Periago and others (1988) demonstrated that olive oil feeding favors 
deposition of 20:4 (n-6) and long chain (n-3) PUFA into rat erythrocyte membrane 
phospholipids. Moreover, olive oil supplemented with medium chain 
triacylglycerol caused a decrease in membrane fluidity as judged by increased 
cholesterol/ phosphorus ratio.
For standard diets containing saturated, mono or (n-6) PUFA, the 
composition of the adipose tissue fatty acids roughly resembles the fatty acid 
composition of the diet (Berry et al, 1986). For diets containing fish oil, however, 
it has been reported that eicosapentaenoic acid and docosahexaenoic acid is not
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stored in adipose tissue in similar proportion to their concentration in the diet (Luo 
et al, 1996).
Rats infused. with fish oil-enriched diets were shown to incorporate 
significantly lower relative percent of linoleic acid 18:2 (n-6) and 20:4 (n-6) into 
rat liver sinusoidal cell phospholipids. Whereas rats infused with olive oil- 
enriched diet only had a lower relative percent of 18:2 (n-6) compared with control 
rats receiving com oil (Palombo et al, 1993). In a similar study, rat liver 
phospholipids showed significant decrease in 20:4 (n-6) after consumption of a 
monounsaturated diet, and n-3 diet. A significant increase in 20:5 (n-3) 
incorporation was observed in n-3 diet feeding and to a lesser extent by feeding the 
monounsaturated fatty acid extraction from fish oil (Halvorsen et al, 1995). 
However, at a dietary fat level of 30% (65% of energy content) the alterations in 
hepatic lipid profile do not show much difference between polyunsaturated and 
saturated fat (Mlekusch et al, 1993). The pattern of incorporation of fatty acids 
may also be determined by the type of tissue besides the fatty acid class. 
Arachidonate (20:4n-6) incorporation was decreased in rat liver while it remained 
unchanged in heart and kidney phospholipids after fish oil ingestion in rats (Cao et 
al, 1995).
Dietary fat:
Impairment of insulin action (insulin resistance) is a major metabolic 
abnormality in individuals with NIDDM, where dietary factors play an important 
role in the development of insulin resistance (Storlien et al, 1991). Insulin secretion
and action are related to the serum phospholipid fatty acid pattern and this close 
relationship provides an opportunity to try to influence glucose tolerance by dietary 
interaction (Pelikanova et al, 1989). Diets high in fat lead to impairment of insulin 
action in the liver and a range peripheral tissues, particularly skeletal muscle, 
which is the major site of insulin-stimulated glucose disposal (Storlien et al, 1991). 
Ramirez et al (1990), reported that a high-fat diet induces an insulin resistant state 
that can be the result of either a decrease in the transport of glucose through the 
plasma membrane or a decreased ability of the cells to metabolize glucose. A high 
fat diet (33.5% hydrogenated vegetable oil, 7.4% com oil) resulted in decreased in 
vitro insulin-stimulated muscle glucose utilization (glycogen synthesis and glucose 
oxidation) and decreased sensitivity to insulin of muscle glycogen synthesis 
(Chicholm and O’Dea, 1987). Several studies have suggested that low-fat, high 
carbohydrate diets exert a positive effect on insulin sensitivity in humans (Lovejoy 
and DiGirolamo, 1992).
Several studies in both animals (Salmon & Flatt, 1985; Hill et al, 1989) 
and humans (Dreon et al, 1988; Miller et al, 1990) have demonstrated an 
association between dietary fat intake and obesity, suggesting that dietary fat may 
influence glucose tolérance. Increased availability of intramuscular triacylglycerol 
contributes to the insulin resistance that develops in high-fat (69%) feeding 
(Kraegen et al, 1989). Studies by Tsujikawa & Kimura (1980) have shown in 
vitro, on isolated white adipocytes of suckling rats that insulin did not stimulate the 
incorporation of glucose into lipids, whereas a large stimulation was
observed in white adipocytes of rats weaned on to a standard HC diet. When the
  2 2  ■
animals weaned on to a HF diet, insulin did not stimulate the incorporation of 
glucose into the lipid of white adipocytes of these animals. These authors have 
also shown that the activities of acetyl-CoA carboxylase and ATP citrate lyase in 
white adipose tissue are very low during the the suckling period and increase 
considerably at weaning on a HC diet, whereas they remain very low in HF- 
weaned rats. Since lipogenesis is one of the major pathways of glucose 
metabolism in white adipose tissue, the low activities of the enzymes in suckling 
and high fat-weaned rats are responsible for the insulin resistance observed in the 
white adipose tissue of these animals (Issad et al, 1988).
Fatty acid composition of the diet is a vital factor in deleterious effects of 
dietary fat on insulin action. Long-chain n-3 fatty acids in phospholipids of 
skeletal muscle is important for efficient insulin action (Storlien et al, 1991). 
Supplementation of high sucrose diets (63%) with n-3-fatty-acids for in rats 4 
weeks improved insulin binding in adipocytes and ameliorated the impaired insulin 
action on glucose incorporation into lipids (Macho et al, 1993).
Studies in rats both in vitro and in vivo have shown that diets high in fat 
lead to impairment of insulin action in the liver and a range of peripheral tissues, 
particularly skeletal muscle, which is the major site of insulin-stimulated glucose 
disposal (Grundler & Theneen, 1982; Kraegen et al, 1986). Harris & Kor, (1992), 
reported that a high fat diet (59% of energy) promotes obesity by depressing 
adipocyte lipolysis A high fat diet was shown to result in decreased insulin 
binding, glucose transport, and glucose metabolism in soleus muscle (Grundler & 
Theneen, 1982).
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Fish oils are a rich source of n-3 fatty acids, characterized by the presence 
of double bond three carbons away from the terminal methyl group. The 
polyunsaturated fatty acids (PUFAs) of the n-3 family are derived from alpha- 
linolenic acid, the main fatty acid in the chloroplast membranes of green plants. 
When these plants are ingested, most of the n-3 Fats are metabolized to long chain 
PUFA, predominantly, Eicosapentaenoic acid (EPA , C22:6) and Docosahexaenoic 
acid (DHA, C22:6). The major sources of these fatty acids in the human diet are 
the oils of fatty fish (British Nutritional Foundation, 1993).
The ingestion of EPA and DHA seems to lower mortality from coronary 
artery disease (Kromhout et al, 1985; Harris, 1989). Such reduced incidence of 
ischemic cardiovascular complications could reflect the lowered plasma cholesterol 
and triacylglycerol concentrations (Dyeberg et al, 1975). Moreover, n-3 fat seems 
to beneficially reduce platelet aggregation, blood rheology (Ernst, 1989), 
fibrinolysis and blood-pressure regulation, thus counter-acting possible risk factors 
of arteriosclerosis. Furthermore, there is a potentially beneficial effect of dietary 
fish-oil supplementation on peripheral insulin resistance, probably subsequent to a 
change in cell membrane composition (Storlien et al, 1986; 1991). Popp-Snijders 
et al (1987) showed that insulin-stimulated glucose uptake in vivo was increased 
by 25% in NIDDM patients after consumption of 3 g n-3 PUFAs/day for 8-weeks. 
Concerning insulin secretion, both augmentation (Lardinois et al, 1987) and 
reduction (Glauber et al, 1988; Panzram, 1987) by (n-3) PUFAs are reported.
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Dietary n-3 PUFA reduce the risk of CHD by various mechanisms; they 
depress plasma lipids, especially triacylglycerol; they replace arachidonic acid 
(AA) in phospholipids with EPA and DHA, which are precursors of a family of 
eicosanoids which are less active than those produced from n-6 PUFAs; 
thromboxane (TXA2) is decreased, reducing the thrombotic tendency of platelets, 
monocytes and macrophages, which may retard the initiation and progress of 
atherogensis by reducing blood pressure; reducing blood viscosity; modulate 
membrane fluidity; and may change enzyme and receptor activities via membrane 
alterations (Kinsella et al, 1990).
Several short-term studies have examined the effect of n-3 PUFAs on blood 
glucose and insulin concentrations in diabetic patients. Recently, Field et al (1988) 
suggested that insulin binding as well as insulin-stimulated glucose transport, 
oxidation and lipogenesis, were significantly increased in adipocytes from rats fed 
on diets containing a high ratio of polyunsaturated to saturated fat. Macho et al 
(1993) reported that dietary supplementation of fish-oil, rich in n-3 PUFA, increase 
the mobility of membrane phospholipid acyl chain, where this contribute the 
amelioration of altered cell membrane functions related to impaired insulin action. 
As to fish-oil action in non-diabetic humans, the substitution of linoleic acid, n-6 
fatty acid and n-3 fatty acid derived from fish-oil prevents impairment of insulin 
action by saturated fat and results improved glucose tolerance in diabetic 
individuals (Fasching et al, 1991). Pscheidl et al (1992) reported, short-term 
feeding with fish-oil improved intestinal lactate clearance in rats, n-3 fatty acids 
improve insulin sensitivity, through their effects on prostaglandin and leuktrienes,
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especially thromboxanes which are involved in insulin secretion (Bathena et al,
1991). The same effects were shown in rats (Vessby & Boberg, 1990).
In olive oil, the amount of oleic and linoleic acids in the 2-glycerol position 
represents 98-99% of the total fatty acid of which oleic, the monounsaturated fat is 
the predominant form, and the saturated fatty acid do not exceed 2% (Tiscomia et 
al, 1982).
Epidemiological evidence shows that Eastern Mediterranean populations 
with a substantial consumption of olive oil (OLO) and a low intake of saturated 
fats have relatively low mortality rates from coronary heart disease (Sirtori et al, 
1986). Oleic acid is the most common monounsaturated fatty acid in the human 
diet and is considered neutral in its influence on total plasma cholesterol 
concentrations because it has an effect similar to that of carbohydrates (Grundy and 
Denke, 1990). Zoppi et al, (1985) found decreased LDL-cholesterol parallel to 
increased of HDL-cholesterol in the patients fed a diet rich in olive oil. Some other 
reports showed that, oleic acid lowers plasma concentrations of total and LDL 
cholesterol without causing a decrease in the concentration of HDL cholesterol 
(Grundy & Denke, 1990; Grundy, 1989). Whereas, high-dose dietary supplements 
of the major polyunsaturated fatty acid of vegetable oil, linoleic acid, induces a 
decrease in plasma total and LDL cholesterol as well as an unfavorable lowering of 
HDL cholesterol (Grundy, 1989; Kromhout et al, 1987). The mechanism 
responsible for the lowering of LDL cholesterol by monounsaturated and 
polyunsaturated fatty acids is thought to be the increased expression of hepatic 
LDL receptors (Grundy & Denke, 1990).
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Weintraub et al, (1988) and Demacker et al, (1991) reported that changes in 
the postprandial metabolism of triacylglycerol-rich lipoproteins have to be 
considered as well to explain the effect of dietary fatty acids on lipo-proteins. Both 
olive-oil and oleic acid feeding results in an accumulation of dihomo-y-linoleic 
acid (DGLA) in liver phosholipids (Periago et al, 1988). The activity of the 
enzyme, desaturase (D5D) which converts DGLA to arachidonic acid (AA, 
20:4n-6) is also lower in the olive-oil-fed than in the com-oil fed animals 
(Borgeson et al, 1988). The increasing DGLA level in turn, might contribute to the 
cholesterol lowering effect of olive-oil; since DGLA serves as the precursor for the 
synthesis of the 1 series prostaglandins which exert many beneficial effects on 
cholesterol and the cardiovascular system (Huang et al 1991).
Com-oil feeding directly affects insulin release from the p-cells by 
changing the membrane fatty acid composition, which may affect glucose- 
stimulated insulin release. Wiersma et al (1993) showed the effect of a high fat 
diet (60% of calories as com-oil) on glucose tolerance, was slightly improved in a 
rat model with a defect in P-cell function, at 3 and 6 months of age. Two weeks of 
feeding of high fat diet (66% fat) resulted in mild impairment of intravenous 
glucose tolerance (Chicholm and O’Dea, 1987). In vivo glucose tolerance tests 
indicate that both basal and glucose stimulated insulin concentrations are elevated 
in rats fed a high fat (com-oil) diet (Harris and Kor, 1992). Sucrose (472.5 g/kg) 
combined with high fat com-oil (39.5 g/kg) induced glucose intolerance 
(Grimditch et al, 1988). Consumption of high fat (66%), low carbohydrate diets 
were shown to result in impaired glucose tolerance and decreased insulin
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sensitivity compared with low fat (12%) high carbohydrate diets fed to male 
Sprague-Dawley rats for 14 days (Chicholm and O’Dea, 1987). Insulin sensitivity 
was reduced in a high fat diet (45%), indicating further that dietary fat mediates a 
reduction in insulin action (Buchanan et al, 1992).
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SUMMARY OF REVIEW
From the preceding literature review it is clear that evidence exists for an 
effect of dietary fat on insulin action and aspects of glucose disposal, with some 
evidence of potentially beneficial influences of polyunsaturated fats (PUFA) of 
both n-6 and n-3 series and possible but as yet poorly studied beneficial effects of 
monounsaturated fats (MUFA), compared with saturated fats (SFA). However 
there is no consensus as to the exact and/or quantitative nature of any effect of the 
composition of dietary fat on glucose disposal and insulin sensitivity. Impairment 
of insulin action (insulin resistance) is a major metabolic abnormality in 
individuals with non-insulin-dependent diabetes mellitus (NIDDM), where dietary 
factors play an important role in the development of insulin resistance. A limited 
amount of work has been published relating to the modifying influence of n-3 
PUFA on glucose tolerance, but no previous studies have examined the influence 
of MUFA as olive-oil, and no study has examined a fish-oil/olive-oil combination 
which is highly relevant to the current interest in the Mediterranean diet. In fact 
there is conflicting data on the effect of fish oil on glucose tolerance in humans 
with NIDDM. Thus low doses of fish oil have been reported to improve insulin 
sensitivity while high doses have been shown to impair glucose tolerance.
Diabetes mellitus is positively associated with saturated fat consumption. 
Studies in rats both in vitro and in vivo have shown that diets high in SFAs lead to 
impairment of insulin action in the liver and a range of peripheral tissues. A high 
SFA diet induce an insulin resistance state either through a decrease in glucose
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transport into cells or through a decreased ability of the cells to metabolize glucose. 
In contrast, populations consuming foods rich in polyunsaturated fatty acids 
(PUFA) have a lower incidence of this disorder. The effect on monounsaturated 
fatty acids (MUFA) on carbohydrate metabolism is unclear. Thus the influence of 
dietary fat on glucose tolerance is important in determining better guidelines for 
dietary requirements for fat in diabetics.
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HYPOTHESIS
Dietary fat quality determines glucose tolerance and insulin sensitivity by 
altering membrane lipid composition and the metabolic responsiveness to 
hormonal stimulation with fish oil improving and saturated fat worsening glucose 
tolerance when fed in high fat diets.
3 1
CHAPTER II 
MATERIALS AND METHODS
The objectives of these studies were to investigate the effects of variation in 
dietary fats on glucose tolerance, insulin sensitivity and membrane fatty acids in male 
Wistar albino rats by ■ feeding com oil (predominantly n-6 PUFA), olive oil 
(monounsaturated predominantly n-9 oleic acid), butter oil (saturated medium chain 
fatty acids; low in n-6 precursors) and fish oil (rich in long chain n-3 PUFA) in 
combination with either olive oil (1:4 & 1:1) and butter oil (1:1).
The analytical methods and experimental techniques used in these studies were
developed and established during the conduct of a series of pilot studies.
Pilot Study I: Application of an intraperitoneal glucose tolerance test to the 
study of insulin glucose tolerance and insulin sensitivity.
Three diets of 20% com oil, 20% olive oil and 4% fish oil + 16% olive oil 
were prepared as showed in Table 2:1. Diets were prepared every week, packed in 
small packs of 500 g and stored in freezer (-20°C).
Table 2:1 Composition of the diets (g/lOOg).
Ingredients Corn oil 
Diet
Olive oil 
diet
Fish oil 
diet
Casein 18 18 18
Corn starch 23.5 23.5 23.5
Sucrose 23.5 23.5 23.5
Cellulose 10 10 10
Corn oil 20 - -
Olive oil - 20 16
Fish oil - - 4
Standard Mineral 
And Vitamin Mix 5 5 5
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In order to allow 3 sequential measurements of the GTT on the three diets a 
total of 63 male Wistar albino rats of similar age weighing 200-220 g were obtained 
from Experimental Animal Care Center, College of Pharmacy, King Saud University, 
Riyadh. They were maintained under the standard conditions of temperature (23 ± 
1°C), humidity (50-55%) and light (12h light and 12h dark cycle). After a week, the 
rats were housed in individual cages and fed with Purina chow diet with free access to 
water during an acclimatization period. The rats were divided into 3 groups (21 rats 
per group) and started on a 20% by weight com oil (CO), olive oil (GO) and fish-oil 
(FO, 4:1 olive oil/fish oil) diet for a period of 2,4 and 6 weeks respectively. Body 
weights and food intakes were recorded daily. Body weights were calculated as mean 
increase in body weight after 2, 4 & 6 weeks respectively Fig 2:1.
Mean food intakes were calculated after 2, 4 and 6 weeks as g/lOOg body 
weight (Fig. 2:2). Significant dietary effects on rats body weights were seen after 4 
weeks of feeding with the com oil group showing a smaller body weight increase. 
However, after 6 weeks the differences were less and not significant. The olive oft 
supplemented group of rats consumed a significantly higher intake of diet as compared 
to com oft and fish + olive oft diet fed rats.
ac 140
5 120
2-weeks 4-w eeks 6-w eeks
Fig 2:1 Mean body weight (g) increased after 2,4 and 6 weeks of dietary &ts sup­
plementations (Mean ±S.E.).
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Fig 2:2 Mean food intake ^lOOg body wdgbt) of rats fed with dietary fats for 2,4 and 6 
weeks (Mean ±S.E.).
Statistically significance were determined by one-way ANOVA and Duncan’s test where 
P<0.05. Dietary groiq)s conyared with eadi odier: a’ ccnn oil, ‘b’ olive oil and ‘c’ fish oil + 
ohve oil (1:4). Six rats were used in eadh group.
Intraperitoneally (ip) glucose tolerance tests were performed after 2, 4 and 6 
weeks of treatment period. After an overnight fast the rats were anesthetized with 
urethane (20% w/v, 0.5 ml/lOOg body weight, ip), and placed on a warming pad. 
Through a ventral midline neck incision, the left carotid artery was catheterized with 
24.5 gauge catheter. After a baseline blood sample (400 pi, as fasting sample), was 
taken glucose 50 mg/lOOg body weight was rapidly injected intraperitoneally, and 
volume of further blood samples (400pl) were collected at 3,6,9,12 and 15 min in 
micro-centrifiige tubes. The blood samples were centrifiiged at 5,000 rpm for 10 min. 
and the serum samples were stored in fi^eezer (-20°C) till glucose and insulin 
estimations. The rats were sacrificed after the blood samples were drawn and in the 6- 
weeks fed group organs were dissected to examine the changes in body composition. 
Liver, spleen, kidney, heart and epididymal fat pads were excised and weighed. The 
weights were calculated as g/lOOg body weight.
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The influence of the supplemented diets on body composition by organ 
weights at 6-weeks is shown in table 2:2. Although there was a suggestion of less 
body fat in the FO group with a lower mean fat-pad weight compared with the other 
two dietary groups, no significant dietary effects on any organ weights were observed.
Table 2:2 Organ-weights (g/lOOg body wt) of rats fed with corn oil (20%), olive oil 
(20%) and fish oil (4%) + olive oil (16%) diets for the period of 6-weeks (Mean 
± S.E.)
Groups Liver Spleen Heart Kidney
Epididymal
fat-pads
3.10 0.38 0.36 0.58 1.56
Corn oil (20%) ± ± ± ± ±
0.08 0.02 0.02 0.02 0.13
3.19 0.39 0.37 0.58 1.53
Olive oil (20%) ± ± ± . d: , ±
0.12 0.03 0.02 0.01 0.28
Fish oil (4%) 2.96 0.33 0.35 0.605 1.40
+ ± ± ± ±
Olive oil (16%) 0.05 0.03 0.01 0.013 0.02
Statistically all dietary groiips were compared to each other by using the one-way ANOVA 
Six rats were used in each group.
The serum samples were analyzed for glucose concentrations by using a 
diagnostic kit (Cat no. 10260 Q10123, Human diagnostics, Germany) and color 
intensity was observed at 500 nm, on a spectrophotometer (Pharmacia LKB, 
England). Serum insulin levels were measured by using an ELISA kit obtained from 
Boehringer Mannheim (EIA Method).
The results are shown in table 2:3. The mean fasting glucose and insulin levels 
did not show any significant dietary effects.
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Table 2:3 Fasting serum glucose and insulin levels of rats fed with com oil (20%), olive 
oil (20%) and fish oil (4%) + olive oil (16%) diets for 2,4, and 6 weeks (Mean ± 
S.E.)
Groups Fastiu g Glucose (uMol/L) Fastimg insulin (uU/ml)
2-weeks 4-weeks 6-weeks 2-weeks 4-weeks 6-weeks
9.92 10.6 10.2 34.0 60.5 56.8
Com oil (20%) ± ± ± ± ± ±
0.56 0.78 0.55 4.38 8.65 5.95
8.80 11.3 10.1 38.1 56.7 59.8
Olive oil (20%) ± ± ± ± ± ±
0.57 0.57 0.43 4.74 6.16 8.49
Fish oil (4%) 9.24 10.4 10.7 49.9 73.8 65.6
+ ± ± ± ± ± ±
OUve oil (16%) 0.35 0.68 0.32 5.14 9.18 9.35
Statistically significance were determined by one-way ANOVA and Duncan’s test. 
Six rats were used in each group.
The changes in serum glucose levels after the intraperitoneal injection are 
shown in Figs. 2:3 -  2:5 after 2, 4 and 6 weeks of dietary treatments respectively. The 
changes in concentration were slower than expected so that glucose tolerance could 
not be assessed quantitatively. Nevertheless the responses were examined in an 
atten^t to identify any dietary effects.
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Figs 2:3 Mean serum glucose after an i.p. Glucose injection (50mg/100g) to rats 
supplemented with com-oil, olive-oil and fish-oil diets for 2 weeks.
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Figs 2:4 Mean serum glucose after an i.p. Glucose injection (SOmg/lOOg) to rats 
supplemented with com-oil, olive-oil and fish-oil diets for 4 weeks.
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Fig 2:5 Mean serum glucose after an Lp. glucose injection (50n%/100g) to rats
supplemented with com oil, olive oil and fish oil diets for the period of 6-weeks.
The mean serum glucose did not achieve maximum levels until 12-15 mins in 
each of the dietary groups. Although after two weeks the peak value was highest in the 
fish oil diet group (21.2 ± 1.4) the diSerences were small among the groups (com oil 
diet: 19.6 ± 1.6; olive oil diet 18.9 ±1.0 Fig. 2:5). No dietary influence was obvious 
when the responses at 2, 4 and 6 weeks were examined together (Fig. 2:3 - 2:5).
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Fig. 2:6 Mean insulin disappearance pattern after a glucose (SOmg/lOOg, Lp.) injection to 
rats snpplmnented with com oil, olive oil and fish oil diets for 2 weeks.
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Fig 2:7 Mean insulin disappearance pattern after a glucose (50mg/100g, i.p.) injection to 
rats supplmnented with com ofl, olive oil and fish oil diets for 4 weeks.
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Fig. 2:8 Mean insulin disappearance pattem after a glucose (SOmg/lOt^, Lp.) injection to 
rats supplemented with com-oil, olive-oil and fish-oil diets for 6-weeks.
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Serum insulin levels generally increased and remained elevated over the 15 
minutes in all dietary groups with the exception of the com-oil group at 2-weeks 
which exhibited little response (Fig. 2:6-2:8). Although insulin levels tended to be 
higher in the fish oil groups especially after 2 and 6 weeks the relative responses of 
the com oil and olive oil group varied between the 2,4 and 6 weeks studies with no 
obvious pattern apparent.
Table 2:4 Fatty acid composition of rat liver membranes as affected by corn oil, olive 
oil and fish oil diets over a period of 6 weeks (Average of 3-pooled 
samples/group).
FATTY ACID C-NUMBER
PERCENT COMPOSITION
CORN-OIL OLIVE-OIL FISH-OIL
Palmitic C16:0 24.6 21.2 19.5
Stearic C18:0 12.9 18.6 20.3
Oleic C18:l 11.3 20.2 16.2
Linoleic C18:2 24.6 9.75 10.9
Eicosanoic C20:l 635 8.94 63W
Arachidonic C20:4 23.1 21.4 13.4
Eicosapentanoic . C20:5
- -
4.05
Docosatetranoic C22:4
- -
____1.40
Docosahexanoic C22:6
- -
7.34
Total 100 100 100
In this study, the influence of dietary fats on tissue phospholipid content was 
examined in terms of the fatty acid composition of the rat liver membrane (for method 
see page 44). Mean values of pooled samples are shown in (Table 2:4). In the com oil 
diet fed group mean values of palmitic acid (C16:0) 24%, linoleic acid (Cl 8:2) 24%
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and arachidonic acid (C20:4) 23% were higher as compared to the olive and fish oil 
group. Olive oil induced a higher value for oleic acid (C l8:1, 20%) and eicosanoic acid 
(C20:l, 9%) compared with the other dietary groups. Eicosapentanoic acid (C20:5, 
4%), docosatetranoic acid (C22:4, 1.4%) and docosahexanoic acid (C22:6, 7% ) were 
only detected in the fish oil + olive oil group.
Pilot Study II
It was clear from the results of the first pilot study that the intraperitoneal 
injection route for the glucose administration was inappropriate. The slow rise to peak 
glucose concentrations meant that no satisfactory analysis of glucose disappearance 
rate could be measured. Thus a pilot study of an intravenous glucose tolerance test was 
carried out.
Four male Wistar rats of similar age weighing 200-220g were obtained and kept 
in individual cages for a week with free access to rat chow and drinking water. After an 
overnight fast, the rats were anaesthetized with urethane (20% w/v, 0.5 ml/lOOg i.p. 
body weight) and placed on a warming operating table. Through a ventral midline neck 
incision, the left carotid artery was catheterized. After a baseline sample (400 pi) was 
taken, heparin (1,000 lU/kg) and then glucose (50 mg as 0.5mF100g body weight) were 
rapidly injected through the same catheter (Davidson and Garvey, 1993). After 
flushing the catheter, further blood samples (400pi) were collected at the same times as 
in pilot study-I and centriftiged at 5,000 rpm for 10 minutes. The plasma samples were 
stored at -20°C till analysis for glucose and insulin levels. Plasma samples were 
analyzed for glucose concentrations by using a diagnostic kit (Human Diagnostics, 
Germany). Glucose disappearance rate (k-value) was calculated as described by
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Davidson and Garvey, (1993). The results were plotted against time on semilogarithm 
paper. The best straight-line fit was obtained by the method of least squares, and the 
line extrapolated back to time 0. The k-value was derived fi'om the following equation 
k(%/min) = 69.3/tV ,^ where VÆ is the time in minutes required for the glucose level 
fi'om any value to fall to one-half of that value.
As indicated in fig. 2:9 showing the glucose responses in the four rats 
studied, it was immediately apparent that the intravenous route of glucose 
administration was much better in that the glucose level increased to a peak at 3 
minutes Ailing rapidly after this. As shown in table 2:5 the mean 50% reduction time 
(tî4) varied between 19.5 and 26.4 minutes (mean 21.8 minutes) resulting in a mean k- 
value of 3.21 %/min.
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Fig 2:9 Serum glucose disappearance pattern after intravenous 
glucose (SOmg/lOOg) in normal rats.
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Table 2:5 Mean fasting glucose and glucose disappearance rate (k-value) in normal
rats.
Rat No. Fasting serum 
glucose (mmol/L)
t% K-value 
(mMole% per min)
1 7.84 19.54 3.54
2 7.27 26.35 2.63
3 7.70 21.26 3.25
4 7.69 20.22 3.43
Mean 7.62 21.84 3.21
± ± ± ±
S.E. 0.12 1.54 0.20
Experiment - 1
After the pilot studies, the reproducibility of the results indicated that intra- 
arterial glucose injection route would allow a satisfactory measurements which would 
allow investigation of the effects of the dietary fatty acids on of glucose tolerance.
A total of 24 male Wistar rats of similar age group, weighing 150-160 g were 
maintained under the standard conditions of temperature (23 ± 1°C), humidity (50- 
55%) and light (12h light and 12 h dark cycle). The rats were housed in separate 
cages (one in each cage) and fed rat chow and had free access to water.
After the adjustment period, rats were divided in 4 groups and fed with dietary 
fats according to the experimental design (Table 2:6). The composition of the diets is 
given in Table 2:7. Diets were prepared every week, packed in small packs of 500 g 
and stored in freezer (-20°C).
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Table 2:6 Experimental design.
Dietary treatments No. of rats Duration
(weeks)
Corn oil (20%) diet 6 5
Olive oil (20%) diet 6 5
Butter oil (20%) diet 6 5
Fish oil (16% olive oil + 4% fish oil) diet 6 5
Body weights and food intakes were recorded daily. The final body weight 
increase after 5-weeks and the mean daily food intake (g/lOOg body weight) was 
calculated for each week.
Table 2:7 Composition of the diets (g/lOOg):
Ingredients Corn-oil
diet
Olive-oil
diet
Butter-oil
diet
Fish-oil
diet
Casein 18 18 18 18
Corn Starch 23.5 23.5 23.5 23.5
Sucrose 23.5 23.5 23.5 23.5
Cellulose • 10 10 10 10
Corn-oil 20
Olive-oil . 20 16
Butter oil 20
Fish-oil 4
Standard 
Mineral and 5 5 5 5
Vitamin Mix
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Glucose Tolerance tests:
After an overnight fast, the rats were anaesthetized with urethane (20% w/v; 
0.5ml/100g body weight i.v.) and placed on a warming operating pad. Through a 
ventral midline neck incision, the left carotid artery was catheterized. After a baseline 
sample the glucose was loaded and the timed blood samples were collected as 
described in the pilot study II. Centrifuged and the plasma samples stored at -20°C 
till glucose and insulin measurements.
All the animals were sacrificed after the blood samples were drawn and 
dissected. Liver, heart, kidney, spleen and epididymal fat pads were excised and 
weighed. The organ weights were calculated as g/lOOg body weight. Two pooled 
liver samples from each group (three rats were used for each pooled sample) were 
refrigerated (+4°C) and membrane phospholipids were measured. Plasma samples 
were analyzed for glucose concentrations by using a diagnostic kit (Human 
Diagnostics, Germany). The glucose disappearance rate (k-value) was derived as 
described in the pilot study-II. In these studies because of concern for the specificity 
of the ELISA insulin assay used in previous studies it was decided to measure plasma 
insulin concentrations by a radioimmunoassay (RIA) kit, (Coat-A-count INSULIN) 
supplied by DPC (Los Angeles, CA), USA (as described in appendix). The insulin 
area under the curve (AUC) at 15 minutes, insulinogenic index (insulin/glucose) and 
insulin sensitivity (k-value/AUC) were calculated by using a computer software “Mini 
Stat”.
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Estimation of membrane fatty acids in hepatic cells:
The isolation of membranes was carried out by the following method of Kates 
(1975). Pooled liver samples were homogenized in a buffer containing 50 mM NaCl, 
ImM CaClz and 10 mM Tris HCl at pH 7.5. After homogenization by a sonicator, the 
homogenate was centrifuged at 8,000 rpm for 15 min and the pellet discarded. The 
supernatant was centrifuged again at 38,000 rpm for 1 hr in the ultracentrifuge. The 
pellet obtained was resuspended in 6 ml of buffer and flushed 10 times through a 22- 
gauge needle and ultracentrifugation was repeated for an additional 1 hr at 38,000 
rpm. The pellet was removed for extraction of membrane lipids.
Lipids in membranes were extracted by the method of Folch et al (1957). The 
preparation of the samples for analysis by gas chromatography is described in full in 
the appendix A brief account is included here. The pellets obtained as above were 
suspended in 2 ml of chloroform/methanol (2:1) solvent and sonicated. The 
homogenate was centrifuged at 2500 rpm and the clear supernatant was collected in a 
tube. The process of washing the homogenate was repeated three times and the 
pooled supernatant from all the washes was mixed with % volume of normal saline 
and vortexed for 1 minute. The lower organic layer was taken out and evaporated to 
dryness by blowing nitrogen gas through it. To this extract, 10 ml of benzene: 
methanol: cone, sulphuric acid (10:84:4) was added and capped in Pyrex glass tubes, 
placed in water bath and heated for 90 minutes at 80-90°C. The tubes were cooled 
and distilled water was added to the tubes followed by washing with hexane. The
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process was repeated three times and the hexane was used for injection into gas 
chromatograph (GC) for fatty acid analysis.
A gas chromatograph, Hewlett Packard, 5840A, was used for fatty acid 
estimation. Column dimensions were 6ft x 2 mm, and the stationary phase used was 
5% diethylene glycol succinate. Nitrogen was the carrier gas at a flow rate of 20 
ml/min at 120 - 185°C with a programmed rate of increase of 2°C/min. The detector 
used was flame ionization detector (FID) at a temperature of 250°C. The fatty acid 
standards were obtained from Sigma (USA).
Experiment II
This experiment was a further development of the previous study. However 
two dietary changes were introduced. Firstly because of concern that the 20% fat diet 
may be excessive for the rat, a lower fat diet (10%) was used. Secondly in order to 
maximized any effects of fish oil the proportion of fish oil was increased to 50:50 
with olive oil. Thus in experiment-II the dietary treatment was com oil (10%), olive 
oil (10%), butter oil (10%) and the combination of fish oil (5%) with olive oil (5%) 
diets. The effects of these diets on intravenous glucose tolerance and insulin 
sensitivity was studied.
This study was carried out in collaboration with a fellow investigator (Iqbal, 
1997), whose project had focused on effects of dietary fats on metabolic response to 
trauma in rats. Only the data on control (non-trauma) animals is reported here.
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A total of 24 male Wistar rats of similar age group, weighing 240-260g were 
obtained from Experimental Animal Care Center, College of Pharmacy, King Saud 
University, Riyadh, K.S.A. They were maintained as described in the pilot studies. 
They were housed in separate cages (one in each cage) and fed rat chow and had free 
access to water. After the adjustment period, the rats were divided in 4 groups and fed 
(free access to food ) with the dietary fats prepared as described in table 2:8 for the 
period of 5-weeks. Diets were prepared every week described in table 2:9, packed in 
small packs of 500g and stored in freezer (-20°C).
Table 2:8 Composition of diets (g/lOOg):
Ingredients Corn oil 
diet
Olive oil 
diet
Butter oil 
diet
Fish oil 
diet
Casein 18 18 18 18
Corn starch 28.5 28.5 28.5 28.5
Sucrose 28.5 28.5 28.5 28.5
Cellulose 10 10 10 10
Corn oil 10
Olive oil 10 5
Butter oil : 10
Fish oil 5
Standard Mineral 
&
Vitamin mix
5 5 5 5
Body weight and food intake were daily recorded. Mean body weight increase after 
5-weeks and mean food intake per week as g/lOOg body weight was calculated.
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Glucose tolerance test:
After an overnight fast, the rats were anaesthetized with urethane (20% w/v; 
0.5ml/100g i.p.) and placed on a warming pad. The intra-arterial glucose tolerance 
test was performed as described in pilot study-II. The timed blood samples were 
collected, centrifuged and the plasma samples were stored at -20° C till glucose and 
insulin measurements were carried out.
All the animals were sacrificed after the blood samples were drawn and 
dissected. Liver, heart, kidney, spleen and epididymal fat pads were excised and 
weighed. Plasma samples were analyzed for glucose concentrations by using a 
diagnostic kit (Human Diagnostics, Germany). The glucose disappearance rate (k- 
value) was derived as described in the pilot study-II. Plasma insulin concentrations 
were measured by a radioimmunoassay kit (Coat-A-Count INSULIN) supplied by 
DPC, Los Angeles. Insulin AUC insulin sensitivity (AUC/K-value) were calculated 
as described in experiment-I. The ratio of plasma insulin to glucose levels was used 
to compute an insulinogenic index or an index of a-cell response to changing glucose 
stimulus (Seltzer et al, 1967).
Experiment III
The objective of the present study was to resolve the discrepancy of glucose 
tolerance and insulin sensitivity results of experiment-I and II. A number of changes 
were introduced. Firstly a control group based on standard rat chow was included. 
Secondly a dietary fat level of 20% was chosen so that a true comparison with 
experiment I could be made. Thirdly in order to asses the effects of fish oil two diets
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were used, i.e. fish oil combined with either butter oil or olive oil. Finally in order to 
ensure that food intake was controlled rats were fed a specific amount each day 
calculated, after measuring the food intakes of rats in experiment-I and II, at a level 
which could be expected to be consumed by all rats but which allowed reasonable 
growth rates. Thus six groups were used in all: control (rat chow), com oil (20%), 
olive oil (20%), butter oil (20%), fish oil (10%) + olive oil (10%) and fish oil (10%) + 
butter oil (10%) and these diets were fed to male Wistar rats for the period of 5-weeks. 
Growth, body composition, glucose tolerance, insulin sensitivity and membrane 
phospholipids were measured.
A total of 36 male Wistar rats of similar age group, weighing 150-160 g were 
maintained under the standard conditions of temperature (23 ± 1°C), humidity (50- 
55%) and light (12h light and 12 h dark cycle). The rats were housed in separate 
cages (one in each cage) and divided in 6 groups. After the adjustment period (a 
week), the rats were fed with rat chow and dietary fats according to the experimental 
design (Table 2:9). Control group of rats were kept on free access to food throughout 
the period (5-weeks). The diets, prepared as shown in table 2:10, were fed 7.5 g/lOOg 
body weight per day to each rat for first three weeks, and the last two weeks continued 
with 7. Og/1 OOg/day.
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Table 2:9 Experimental design.
Dietary
Feeding pattern (g/lOOg 
body weight/day/rat) No of rats Duration
treatments Week 1-3 Week 4-5 used
Control (Rat chow)
Free access 
to food
Free access 
to food 6 5
Corn oil (20%) 7.5 7.0 6 5
Olive oil (20%) 7.5 7.0 6 5
Butter oil (20%) 7.5 7.0 6 5
Fish oil (10%)
+
olive oil (10%)
7.5 7.0 6 5
Fish oil (10%)
+
butter oil (10%
7.5 7.0 6 5
The composition of diets is shown in table 2:10. The diets were prepared every 
week, packed in small packs of 500g and stored in freezer (-20°C).
Table 2:10 Composition of diets (g/lOOg).
Ingredients
Corn oil 
diet
Olive oil 
Diet
Butter oil 
diet
Fish oil
+
Olive oil
Fish oil
+
Butter oil 
diet
Casein 18 18 18 18 18
Corn starch 23.5 23.5 23.5 23.5 23.5
Sucrose 23.5 23.5 23.5 23.5 23.5
Cellulose 10 10 10 10 10
Corn oil 20 . . .
Olive oil . 20 . 10
Butter oil . . 20 . 10
Fish oil . . . 10 10
Standard mineral and 
vitamin mix 5 5 5 5 5
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Body weights were recorded daily and mean weight increased after 5-weeks 
was calculated. Intravenous glucose tolerance test was performed as described in 
previous studies. After an overnight fast, the rats were anaesthetized, through a 
ventral midline neck incision; the left carotid arteiy was catheterized. The timed 
blood samples were collected as described in the pilot study II. After the timed blood 
samples were drawn, blood was collected as much as possible through cardiac 
puncture and reftrigerated. All the animals were sacrificed after the blood samples 
were drawn and dissected. Liver, heart, kidney, spleen and fat pads (perirenal fat, 
mesentric fat and epididymal fat) were excised and weighed. Two pooled liver 
samples from each group was kept in refrigerator to estimate the membrane 
phospholipids. Plasma samples were analyzed for glucose concentrations by using a 
diagnostic kit (Human’s Diagnostics, Germany). The k-value were calculated as 
described in pilot study-II. Plasma insulin levels were measured by a 
radioimmunoassay kit (Coat-A-Count INSULIN) supplied by DPC, Los Angeles, 
USA. Insulin AUC, insulinogenic index and insulin sensitivity were calculated as 
described in experiment-I.
Estimation of membrane fatty acids in erythrocytes and in hepatic cells:
Three blood samples from each group were pooled and centrifuged at 8,000 
rpm for 1 min, 10ml packed cells were washed 5 times with 100 ml normal saline. 
The final washed cells were subjected to hypotonic lysis with 150 ml chilled 10 
mmolar Tris-HCl buffer, pH 7.4. The isolation of membranes was carried out as 
described in experiment-I by following the method of Kates, (1975).
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Statistical Analysis:
The distribution of the data in each group was tested for normality by the 
Shapiro-Wilks W test prior to further testing. The statistical significance of any 
differences between groups was then assessed by the one-way ANOVA and post-hoc 
testing by Duncan’s test to identify differences between individual groups. P- value 
less than 0.05 were considered as significant.
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CHAPTER III 
RESULTS
EXPERIMENT — I: The effect of corn oil (20%), olive oil (20%), butter oil 
(20%) and fish oil (4%) + olive oil (16%) on glucose tolerance, 
insulin sensitivity and phospholipids of hepatic cell membranes in 
male Wistar rats.
Body weights and food intakes:
The mean changes in body weight increased of rats fed with dietary fats is 
shown in table 3:1. There were significant dietary effects on growth during the 5- 
week trial with weight gain varying in the order olive oil = butter oil> com oil=fish oil 
with the fish oil group exhibiting the lowest and olive oil the highest mean growth 
rates. Thus it is clear from this that the presence of fish oil at 4% markedly reduced 
the weight gain with the olive oil.
Table 3:1 Mean body weights and body weight increases of rats supplemented with 
corn oil (20%), olive oil (20%), butter oil (20%) and fish oil (4%) + olive oil 
(16%) for the period of 5-weeks (Mean ± S.E.).
Groups Initial body 
Weight (g)
Body weight 
Increase 
in 5-weeks (g)
Final body 
Weight (g)
Corn oil 152 92.1 h 243
(2 0 %) ± ± ±
2.94 9.62 9.01
Olive oil 150 131 M 281
(2 0 %) ± ± ±
4.12 7.14 6.91
Butter oil 155 119(1 274
(2 0 %) ± ± ±
3.28 9.90 10.6
Fish oil (4%) 154 84.8 h,c 239
+ ± ± ±
Olive oil (16%) 1.93 10.3 11.1
Statistically significance was determined by one-way ANOVA and Duncan’s test.
Letters refer to significance at the P<0.05 level, ‘a’ com oil, ‘b’ olive oil, ‘c’ butter oil and 
‘d’ fish oil + olive oil (1:4).
Six rats were used in each group.
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In contrast to these marked differences in growth rates between the dietary 
groups, the rats fed the four diets for 5-weeks, did not show any significant changes in 
their food intakes during the experiment (Table 3:2). However the mean food intakes 
during 4* and 5* weeks was tended to be greater in olive oil compared with the fish 
oil group and this could have accounted for the growth had the values been 
significant.
Table 3:2 Food intakes (g/lOOg body weight) of rats supplemented with corn oil (20%), 
olive oil (20%), butter oil (20%) and fish oil (4%) + olive oil (16%) diets for the 
period of 5-weeks (Mean ± S.E.).
ist 2nd 3 rd 4th 5th
Groups week week week week week
Corn-oil 8.18 7.34 6.30 5.71 6.48
(20%) ' ± ± ± ± it
0.38 0.32 0.48 0.38 0.28
Olive-oil 7.82 7.32 7.42 6.54 7.01
(20%) ± ± ± ± ±
0.52 0.28 0.40 0.36 0.56
Butter-oil 8.68 7.06 7.12 6.99 6.24
(20%) ± ± ± ± ±
0.36 0.28 0.61 0.27 0.34
Fish-oil (4%) 8.05 7.67 7.18 6.03 5.83
+ ± ± ± ± ±
Olive oil (16%) 0.57 0.49 0.36 0.26 0.18
Statistically significance was determined by one-way ANOVA and Duncan’s test P < 0.05. 
Six rats were used in each group.
Body composition:
The influence of dietary fats on body composition as indicated by organ 
weight (g/lOOg body weight) is shown in table 3:3. No significant differences 
were seen in liver, spleen and kidney weight between any of the dietary groups. 
However the heart weight was significant (P<0.05) reduced in the fish oil + olive
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oil diet fed rats as compared to the com oil, olive oil and butter oil groups, 
respectively. The weight of epididymal fat pads were significantly increased in the 
olive oil and butter oil fed animals as compared to com oil and fish oil + olive oil 
groups, respectively. This suggest that differences in body fat accounted for some 
of the differenmces in body weight.
Table 3:3 Organ-weights of rats supplemented with corn oil (20%), olive oil (20%), 
butter oil (20%) and fish oil (4%) + olive oil (16%) diets for the period of 5- 
weeks.
Groups
Organs weight (g/lOOg body weight) Mean ± S.E.
Heart Liver Spleen Kidney Epididymal 
fat pads
Corn-oil 0.45 “ 3.25 0.38 0.74 1.02
(2 0 %) ± ± ± ±
0.03 0.07 0.04 0.04 0.07
Olive-oil 0.43" 3.33 0.35 0.67 1.26
(2 0 %) ± ± ± i ±
0.02 0.08 0.03 0.02 0.05
Butter-oil 0.42" 3.09 0.32 0.67 1.25 ' "
(2 0%) db ± ± ± ±
0.01 0.10 0.01 0.01 0.14
Fish-oil (4%)
+
Olive oil (16%)
0.38
±
0.01
3.28
±
0.06
0.39
i
0.05
0.70
±
0.02
0.98
i t
0.10
Statistically significance was determined by one-way ANOVA and Duncan’s test.
Letters refer to significance at the p<0.05 level, ‘a’ com oil, ‘b’ olive oil, ‘c’ butter oil and 
‘d’ fish oil.
Six rats were used in each group.
Glucose decay curves and insulin response:
The mean changes in the semm glucose disappearance pattems after the 
intravenous glucose in the rats fed the dietary fats for 5-weeks is shown in fig 3:1. 
After the glucose injection (50 mg/lOOg body weight, i.v.) the semm glucose levels 
reached their highest peak at 3 minutes in all groups falling rapidly after that time. In 
the fish oil group the glucose levels decreased the most, from 24.8 (3 min) to 12.5
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mMoles/L at 15 min while in the olive oil group it fell more slowly from 24.2 (at 3 
min) to 17.8 mMoles/L at 15 min.
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Fig 3:1 Mean semm glucose disappearance pattern after intravenous glucose in rats 
supplemented with com-oil (20%), oBve-oil (20%), butter-oil (20%) and fish-oil 
(4%) + olive oil (16%) diets for the period of 5 weeks.
Table 3.4: Semm glucose concentrations (date of above curves) at minutes 0,3,6,9,12 and 
15 of rats after the first baseline sample a glucose load of 50 n%/100mg body 
weight i.v. was given.
Groups O-min 3-min 6-min 9-min 12-min 15-min
Com oil 12.0 25.6 22.7 19.1 16.8 13.9”
(20%) ± ± ± ± ± ±
0.31 0.48 0.39 0.44 0.28 0.32
Olive oil 11.7 24.2 22.6 21.0 19.4 17.8
(20%) i ± ± ± ± ±
0.27 0.51 0.38 0.33 0.21 0.30
Butter oil (20%) 9.31 23.7 21.8 19.9 17.0 15.3”
± ± ± ± ± ±
0.19 0.38 0.41 0.33 0.28 0.21
Fish oil (4%) 10.3 24.8 22.5 17.1 15.8 12.5”
+ ± ± ± ± db ±
Olive oil (16%) 0.28 0.56 0.41 0.35 0.28 0.23
Statistically significance was applied only at 15-min glucose concentrations by one-way 
ANOVA and Duncan’s test.
Letters refer to significance at P<0.05 level, ‘a’ com oil, ‘b’ olive oil, ‘c’ butter oil and ‘d’ fish 
oil + olive oil (1:4).
Six rats were used in each group
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The mean changes in serum insulin after the intravenous glucose load in all the 
groups is given in Fig 3:2. After the glucose injection, insulin levels increased reaching 
a maximum at 3 minutes and then fell towards initial baseline values. Relative to the 
baseline values the highest increase occurred in the com-oil (30%) and fish-oil group 
(22%) with lower increases in the olive-oil (19%) and butter-oil (13%) groups.
200
150
100
50
0 4—  
O-min 3-min 6-min 9-min 15-min
‘Corn oil ‘Olive oil Butter oil ‘Fish oil
Fig 3:2 Mean serum insulin after intravenous glucose in rats supplemented with com oil 
(20%), olive oil (20%), butter ofl (20%) and fish oil (4%) + olive oil (16%) diets 
for the period of 5 weeks.
Table 3:5: Serum insulin concentrations (pU/ml) at minutes 0 ,3 ,6 ,  9 ,12 and 15 of rats 
fed with com oil (20%), olive ofl (20%) butter ofl (20%) and fish ofl (4%) + olive 
ofl (16%) for the period of 5-werics, after the first baseline sample load of 50 
mg/lOOmg body weight i.v. was given.
Groups O-min 3-min 6-min 9-min 12-min 15-min
Comoil 75.2 174 119 116 104 82.3
(20%) ± i ± ± ± ±
4.93 9.78 10.1 8.76 7.54 6.84
CHiveoil 62.5 123 105 97.0 90.0 75.7
(20%) db ± ± ± ± ±
6.92 11.7 10.8 8.43 9.72 9.88
Butter oU 70.3 118 111 100 86.5 78.8
(20%) ± ± ± ± db
7.58 9.89 10.8 7.56 8.34 8.56
Fish oil (4%) 98.3 181 150 141 123 113
+ ± ± ± ± ± ±
Olive oil (16%) 9.78 16.8 15.3 14.8 15.4 13.9
ANOVA and Duncan’s test.
Six rats were used in eadi dietary group.
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Glucose intolerance and insulin sensitivity:
Feeding these four 20% fat diets for 5-weeks did not significantly influence 
plasma fasting glucose and insulin concentrations within the groups. However the 
glucose disappearance rate (k-value) was significantly slower in the olive oil diet fed 
groups as compared to com oil and fish oil + olive oil groups respectively (Table 3:7). 
There were no significant dietary effects on the insulin area under the curve over the 
15 minutes (AUC) (Table 3:7) but calculation of the insulin sensitivity as (k- 
value/AUCxlO^) indicated a significantly lower value for the olive oil diet group 
compared with the other dietary groups with the highest mean value for the fish oil 
fed group. However this latter value was not significantly higher than the com oil or 
butter oil group.
Table 3:6 Mean fasting glucose, fasting insulin, glucose disappearance rate (k-value), 
insulin area under the curve and insulin sensitivity in rats fed with corn oil 
(20%), olive oil (20%), butter oil (20%), and fish oil (4%) + olive oil (16%) for 
the period of 5-weeks (Mean ± S.E.).
Groups Fasting
glucose
(mMol/L)
Fasting
insulin
(pU/ml)
k-value
(%/min)
Insulin area 
under the 
curve (AUC)
Insulin
sensitivity
(k/AUC)xl03
Corn oil 11.9 75.2 5.37 b 1779 3.01 b
(2 0%) ± ± ± ± ±
1.13 11.6 0.22 284 0.22
Olive oil 11.7 62.5 2.77 M 1451 2.08 a,c,d
(2 0%) ± d= ± db ±
1.38 14.8 0.39 269 0.10
Butter oil 9.30 70.3 4.81 1429 3.37 b
(2 0 %) ± db ± ifc ±
0.68 7.48 1.02 323 0.41
Fish oil (4%) 10.3 98.3 7.32 b 2096 3.50 b
+ ± ± ± ± ±
Olive oil (16%) 1.06 11.0 1.31 353 0.52
Statistically significance was determined by one-way ANOVA and Duncan’s test.
Letters refer to significance at the P<0.05 level, ‘a’ com oil, ‘b’ olive oil, ‘c’ butter oil and 
‘d’ fish oil + olive oil (1:4). Six rats were used in each group.
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Insulinogenic index:
The insulinogenic index calculated from the insulin to glucose ratio is shown 
is table 3:6. Significantly higher values were fond in fish oil + olive oil (1:4) group as 
compared to com oil, olive oil and butter oil groups.
Table 3:7 Mean insulinogenic index (insulin/glucose) in rats supplemented with 20% 
corn oil, 20% olive oil, 20% butter oil, 4% fish oil + 16% olive oil for the period 
of 5-weeks (Mean ± S.E.)
Groups O-min 3-min 6-min 9-min 12-min 15-min
Corn oil 6.43 6.84 5.31 6.11 6.23 5.96"
(20%) ± ± ± ± ± ±
0.56 0.69 0.71 0.61 0.48 0.81
Olive oil 5.49 5.21 4.70 4.73 4.71 4.68"
(20%) ± ± ± ± ± ±
0.52 0.48 0.76 0.72 0.53 0.39
Butter oil 7.61 5.06 5.13 5.10 5.16 5.19"
(20%) ±. ± ± ± ± ±
0.63 0.59 0.63 0.58 0.54 0.48
Fish oil (4%) 9.67 7.46 6.73 8.32 7.84 9  1 6 a , b , c
+ ± ± ± db ± ±
Olive oil (16%) 0.81 0.89 0.78 0.76 0.59 0.88
Statistically significance was applied only at 15-min ratio by one-way ANOVA and Duncan’s 
test.
Letters refer to significance at P<0.05 level, ‘a’ com oil, ‘b’ olive oil, ‘c’ butter oil and ‘d’ fish 
oil + olive oil (1:4).Six rats were used in each group
Dietary effects on membrane fatty acids:
The fatty acid composition of liver cell membranes isolated from rats fed the 
com oil (20%), olive oil (20%), butter oil (20%) and fish oil (4%) + olive oil (16%) 
diets is given in table 3:8. Total saturated fatty acids were estimated as highest (52%) 
in the butter oil diet group, followed by the com oil diet (49%) olive oil diet (44%) 
and fish oil diet (44%). The n-6 n-3 PUFA ratio was as expected highest (39) in the 
com oil group and lowest in the fish-oil group(Table 3:8). Laurie acid (C12:0) was 
detected only in the com oil and butter oil diet-supplemented groups as 1.0% and
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0.86% respectively. Myristic acid (C14;0) was also found only as a trace (0.2%) in 
the butter oil diet fed group. Stearic acid (Cl 8:0) content varied between the groups.
Table 3:8 Percentage fatty acids composition of the hepatic cell membrane of rats 
supplemented with corn oil (2 0%), olive oil (2 0 %), butter oil (2 0 %), fish oil 
(4%) + butter oil (16%) for the period of 5-weeks.
FATTY ACID
PERCENT COMPOSITION
C-
NUMBER
Corn oil 
(20%)
Olive oil 
(20%)
Butter oil 
(20%)
Fish oil 
(4%) + 
olive oil 
(16%)
LAURIC ACID C12:0 1.05 0.86 .
MYRISTIC C14:0 . 0.21
PALMITIC C16:0 24.1 19.0 29.0 21.4
STEARIC C18:0 24.3 25.2 21.7 22.7
OLEIC ClSrl, 11.4 25.8 24.3 20.4
LINOLEIC C18:2, 23.8 8.55 8.46 9.98
EICOSANOIC C20:l, 0.99 0.53 0.39 0.29
ARACHIDONIC C20:4, 14.3 17.2 10.0 10.4
EICOSAPENTAENOIC C20:5, . . 4.99
DOCOSADIENOIC C22:2, . 0.74 .
DOCOSATETRAENOIC C22:4, . 1.47
DOCOSAHEXAENOIC C22:6, . 3.73 4.39 8.37
TOTAL SEA 49.4 44.2 51.8 44.1
TOTAL PUFA 39.1 30.0 24.0 35.5
PUFA/SFA Ratio 0.79 0.68 0.46 0.80
PUFA/MUFA Ratio 3.43 1.16 0.99 1.74
n-3 PUFA 0.99 4.26 4.78 13.65
n-6 PUFA 38.1 25.7 19.2 21.8
n-6/n-3 Ratio ' 38.5 6.04 4.02 1.60
6 0
As would be expected tbe oleic acid (C l8:1) level in tbe com oil diet group 
was only balf tbat found in tbe otber treatment groups wbile in contrast linoleic acid 
(C l8:2) content was markedly increased in tbe com oil supplemented group as 
compared to tbe otber dietary groups. Low levels of eicosaenoic acid (C20:l) were 
found in all four groups. Aracbidonic acid (C20:4) level was bigbest in tbe olive oil 
group (17%), intermediate (14%) in tbe com oil and lowest in tbe butter oil and fisb 
oil diets supplemented groups. Eicosapentaenoic acid (C20:5) was detected only in 
tbe fisb oil diet fed group. A trace of docosadienoic acid (C22:2) trace was found 
only in tbe butter oil diet fed group. Docosatetraenoic acid (C22:4) trace was detected 
only in tbe fisb oil diet group. Docosabexaenoic acid (C22:6) was detected in all 
groups except for tbe com oil group but its content was bigber in tbe fisb oil diet 
group as compared to tbe butter oil and olive oil diet groups.
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EXPERIMENT - II: The effect of corn oil (10%), olive oil (10%), butter oil 
(10%) and fish oil (5%) + olive oil (5%) diets on glucose
tolerance and insulin sensitivity in male Wistar rats.
Body weight and food intakes:
The influences of the dietary fat on body weight growth is shown in table 3:9. 
In this study with somewhat older rats (250 -  270g) feeding tbe com oil, olive oil 
butter oil and fisb oil + olive oil (1:1) for tbe period of 5-weeks at tbe lower fat 
concentrations of 10% did not produce any significant alterations in body weight 
growth.
Table 3:9 Body weight of rats supplemented with corn oil (10%), olive oil (10%), 
butter oil (10%) and fish oil (5%) + olive oil (5%) for the period of 5-weeks 
(Mean ± S.E.).
Groups
Initial 
body 
weight (g)
Body weight 
increased 
in 5-weeks (g)
Final 
body 
weight (g)
Corn oil 269 75.6 345
(20%) ± ± ±
2.87 4.11 5.02
Olive oil 267 77.0 344
(20%) ± ± ±
2.92 5.63 6.11
Butter oil 261 80.1 341
(20%) ± ±
2.84 5.14 5.67
Fish oil (5%)
+
Olive oil (5%)
260
±
2.76
74.9
±
6.05
335
±
4.89
Statistically significance was determined by one-way ANOVA and Duncan’s test where 
P<0.05. Six rats were used in each group.
Tbe food intakes (g/lOOg body weight per day) in this study are shown in table
3:10. Although after 4-weeks of tbe diets, food intakes were not different between tbe
groups, differences were apparent during tbe first 3 weeks, with bigber intakes in tbe
olive oil diet groups compared to tbe fisb oil + olive oil (1:1) diet. Tbe intake of tbe
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butter oil diet group was also elevated in tbe first 4 weeks compared to tbe fisb oil + 
olive oil (1:1) diet group but tbis was not statistically significant.
Table 3:10 Food intakes (g/lOOg body weight) of rats fed with corn oil (10%), olive oil 
(10%), butter oil (10%) and fish oil (5%) + olive oil (5%) for the period of 5 
weeks (Mean ± S.E.).
Groups 1st
week
2nd
week
3rd
week
4‘h
week
5“*
week
Corn oil 8.24 6.91*’ 7.43 7.65 6.95
(10%) ± ± ± ± ±
0.20 0.24 : 0.30 . 0.39 0.18
Olive oil 8.32 7.63 “’V 7.81'' 6.88 6.57
(10%) ± ± ± ± ±
0.15 0.18 0.32 0.16 0.15
Butter oil 7.68 7.28 7.05 7.16 6.52
(10%) ± ± ± ± ±
0.30 0.31 0.27 0.19 0.15
Fish oil (5%) 1A 9^ 6.77'’ 6.42 6.80 6.56
+ ± ± ± ± ±
Olive oil (5%) 0.26 0.23 0.22 0.24 0.14
Statistically significance was determined by one-way ANOVA and Duncan’s test. 
Letters refer to significance at p<0.05 level.
‘a’ com oil, ‘b’ olive oil, ‘c’ butter oil, ‘d’ fisb oil + olive oil (1:1).
Six rats were used in eacb group.
Body Composition:
No significant dietary effects of tbese 5-week feeding trials were observed for 
liver, spleen and beart weights. However tbe com oil diet significantly (P<0.05) 
increased tbe kidney weight as compared to olive oil diet group. Most importantly 
there was a significant elevation in epididymal fat pad weights in the olive oil and 
butter oil diet groups as compared to tbe com oil and fisb oil + olive oil diet groups 
respectively (Table 3:11).
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Table 3:11 Mean organ weight (g/lOOg body weight) of rats fed with corn oil (10%), 
olive oil (10%), butter oil (10%) and fish oil (5%) for the period of 5-weeks 
(Mean ± S.E.)
Dietary groups Liver Kidney Spleen Heart
Epididymal 
Fat pads
Corn oil 3.05 0.76 b 0.37 038 1.21 b,c
(10%) ± ± ± ± ±
0.19 0.03 0.03 0.01 0.08
Olive oil 2.97 0.67% 0.37 0.39 1.46 a,d
(10%) ± ± ± ± ±
0.14 0.01 0.06 0.01 0.06
Butter oil 2 j# 0.68 0.36 0.37 1.54 %,d
(10%) ± ± ± ± ±
0.07 0.02 0.03 0.01 0.12
Fish oil (5%) 3.13 0.69 0.30 0.37 1.22 b,c
+ ± ± ± ± ±
Olive oil (5%) 0.11 0.02 0.04 0.01 0.06
Statistically significance was determined by one-way ANOVA and Duncan’s test.
Letters refer to significance at P<0.05 level.
‘a’ com oil, ‘b’ olive oil, ‘c’ butter oil, ‘d’ fish oil + olive oil (1:1) and ‘e’ fish oil + butter oil 
(1:1). Six rats were used in each group.
Glucose decay curves and insulin response:
The mean changes in the glucose disappearance patterns after the intravenous 
glucose injection to the rats fed these diets for 5-weeks is shown in figure 3:3, table 
3:12. The plasma glucose levels reached their highest peak at 3 min after the glucose 
load (50mg/100g body weight, i.v.) and concentrations started falling rapidly after that 
time. The glucose disappearance hetween 3 to 15 min was slowest in the hutter oil 
group (30%) compared with the other three groups (i.e. olive oil (38%), fish oil + 
olive oil (37%), com oil (35%).
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Fig 3:3 Glucose toleraoce curves at minutes 0, 3 ,6 ,9 ,1 2  and 15 of rats fed widi (10%) 
Com oil, (10%) Olive ml, (10%) Butter oil, (5%) fish  ofl + (5%) Olive ofl diets 
for a period of 5 weeks.
Table 3:12 Plasma glucose concentrations (date of above curves) at minutes 0,3,6,9,12 
and 15 of rats after the first baseline sample a glucose load of 50mg/100g body 
weight i.v. was ÿvm . Six rats were used in each group and the data shown (Mean
1 Groups 0-min 3-mm 6-min Onnin 12-mm 15-min j
Cora ml 9.02 21.1 18.7 16.8 15.2 13.7
(10%) ± ± ± ± ±
0.30 0.98 0.83 0.71 0.57 0.49
Olive oil 9.63 22.1 19.4 17.2 15.4 13.6
(10%) ± ± ± ± ± ±
0.50 0.43 0.49 0.53 0.46 0.47
Butter ofl 9.13 19.8 18.3 16.6 15.3 13.9
(10%) ± ± ± ± ± *
0.41 0.37 0.34 0.21 0.14 0.18
fish ofl (5%) 9.52 19.3 17.2 15.4 13.8 12.1
+ ± ± ± ± ±
Olive ofl (5%) 0.19 0.69 0.78 0.81 0.87 0.94 1
Statistically significance was ^ lie d  only at 15-min glucose concentrations by one-way 
ANOVA and Duncan’s test (no significant differences observed).
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Fig 3:4 Plasma imniHn levels at minutes 0 ,3 ,6 ,9 ,1 2  and 15 of rats fed wtth (10%) Com oil, 
(10%) OKve oil, (10%) Butter oil, (5%) Fish oil + (5%) OKve oil diets for a period 
of 5 weeks.
Table 3:13 Plasma Insulm concmtratmons at minutes 0 ,3 ,6 ,9 ,1 2  and IS of rats fed with com 
oil (10%), olive oil (10%), butter oil (10%) and fish oil (5%) + olive ofl (5%) for the 
period of 5-weeks, after the first base-line sample a glucose load of 50 mg / 100 g
Groups 0-min 3-min 6-nmn 9-min 12-nun 15-min j
Com ofl 
(10%)
21.0
±
0.80
69.3
±
3.56
65.0
±
4.11
80.4
±
6.33
104
±
5.49
139 M
±
5.61
Olive ofl 20.6 65.0 54.8 65.6 85.8 108"':
(10%) ± ± + + + ±
1.39 4.73 4.43 5.78 7.16 7.58
Butter ofl 25.7 73.9 66.4 73.0 105 146*^
(10%) ± ± ± ± ± ±
1.92 5.22 5.61 9.66 7.92 5.40
Fish ofl (5%) 16.4 57.9 57.7 58.9 76.2 95.1"':
± ± + + + ±1 Olive ofl 6.821 (5%) 2.03 3.47 4.02 4.42 5.86
Statistically sigËficance was apç^ed only at 15-min insulin concentiaticms by one-w^ ANOVA 
and Duncan’s test.
Letters refer to significance at P<0.05 level, ‘a’ com oil, ‘b’ olive oil, ‘c’ butter oil and ‘d’ fish oil 
+ olive oil.
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The mean changes in plasma insulin levels after the glucose injection is 
showed in Fig. 3.4 and Table 3:13. After the glucose administration there was a sharp 
initial increase in insulin levels at 3 minutes in all dietary groups, followed by a 
further increase which was delayed until after 6 minutes when it increased 
progressively throughout the remaining 15 minutes. The final value was highest in 
the butter oil group (146 ± 5p-U/ml) followed by com oil (139 ± 6), olive oil (108 ± 8) 
and fish oil + olive oil (95 ± 7 pU/ml: Table 3:10).
Glucose intolerance and insulin sensitivity:
No significant alterations were seen in fasting glucose concentrations in rats 
fed these 10% fat diets for the 5-weeks. However fasting insulin levels were 
significantly (P<0.05) decreased in the fish oil + olive oil diet fed group as compared 
to the butter oil group. Most importantly the glucose disappearance rate (k-value) was 
significantly elevated in the olive oil and fish oil + olive oil groups, compared to the 
butter oil group (Table 3:14).
The insulin area under the curve (AUC) at min 15 was significantly increased 
in the com oil and butter oil diet groups compared to the olive oil and fish oil + olive 
oil group respectively. Insulin sensitivity (k-value/AUC) was not significantly altered 
by the varying dietary fats. However, in terms of mean values the rats fed with butter 
oil and com oil diets were less insulin sensitive compared to the olive oil and fish oil 
+ olive oil groups respectively (Table 3:14).
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Table 3:14 Mean fasting glucose, fasting insulin, glucose disappearance rate (k-value), 
insulin area under the curve (AUC) and insulin sensitivity in rats feed with corn 
oil (10%), olive oil (10%), butter oil (10%) and fish oil (5%) + olive oil (5%) for 
the period of 5-weeks (Mean ± S.E.).
Groups
Fasting
glucose
(mmole/1)
Fasting
insulin
(pu/ml)
K-value
(%/min)
Insulin 
area under 
the curve 
(AUC)
Insulin
sensitivity
(k-value/
AUCxlO^)
Corn oil 9.02 21.0 3.54 1198 M 298
(10%) ± ± ± ± ±
0.30 0.80 0.30 54.8 0.56
Olive oil 963 20.6 4.03 c 1007 a,c 4.03
(10%) ± ± ± ± ±
0.50 1.39 0.28 47.5 0.70
Butter oil 9.13 25.7 d 2.94  b,d 1216 M 2.49
(10%) ± ± ± ± ±
0.41 1.92 0.20 8L5 0.61
Fish oil (5%) 9.52 16.3 c 3.96 c 919 a,c 4.41
+ ± ± ± ■ ± ±
Olive oil (5%) 0.19 2.03 0.39 47.1 1.49
Statistically significance was determined by one-way ANOVA and Duncan’s test where 
P<0.05. ‘a’ com oil, ‘b’ olive oil, ‘c’ butter oil, ‘d’ fish oil + olive oil (1:1) and ‘e’ fish oil + 
butter oil (1:1).
Six rats were used in eaeh group.
Insulinogenic index:
The insulinogenic index calculated from the insulin to glucose ratio is shown in 
Table 3:15. A significantly lower value at 15 minutes was observed for the olive oil 
and fish oil + olive oil dietary groups compared with the com oil and butter oil 
groups.
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Table 3:15 Mean insulinogenic index (insulin/glucose) in rats supplemented with 10% 
corn oil, 10% olive oil, 10% butter oil and 5% fish oil +5% olive oil for the 
period of 5-weeks (Mean ± S.E.).
Groups 0-min 3-min 6-min 9-min 12-min 15-min
Corn oil 2.34 3.36 4.33 433 6.97 10.3 b,d
(10%) ± rb ± ± ± ±
0.12 0.32 038 0.43 0.54 0.67
Olive oil 2.14 2.95 2.84 337 5.65 8.00 a,c
(10%) ± ± ± ± ± ±
0.12 0.25 0.26 0.46 0.56 0.62
Butter oil 2^3 3.75 3.66 4.42 6.92 10.5 b,d
(10%) ± ± ± ± ± ±
0.20 0.32 0.37 0.64 0.54 0.51
Fish oil (5%) 1.71 2^9 338 338 5.56 7.92 a,c
+ ± ± ± ± ±
Olive oil (5%) 0.19 0.12 0.27 0.34 0.35 0.37
Statistically significance was applied only at 15-min ratio by one-way ANOVA and Duncan’s test 
where P<0.05.
‘a’ com oil, ‘b’ olive oil, ‘c’ butter oil, ‘d’ fish oil + olive oil (1:1) and ‘e’ fish oil + butter 
oil (1:1).
Six rats were used in each group.
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EXPERIMENT -  III: Effect of rat chow, corn oil (20%), olive oil (20%), 
butter oil (20%), fish oil (10%) + olive oil (10%) and fish oil + 
butter oil (10%) diets on glucose tolerance, insulin sensitivity and 
membrane phospholipids in male Wistar rats:
Body weights and food intakes:
In this study the growth responses of the 20% fat diets fed at a fixed amount of 
food intake can be compared with those of the rat chow control group. All dietary 
groups grew well on this regime over the 5-weeks dietary treatment but significant 
dietary affects on growth were observed (Table 3:16).
Table 3:16 Mean body weights and body weight increases of rats fed with rat chow, 
corn oil (2 0 %), olive oil (2 0%), butter oil 2 0%, fish oil (10%) + olive oil (10%) 
and fish oil (10%) + butter oil (10%) for the period of 5-weeks. (Mean ± S.E.).
Groups
Initial 
body 
weight (g)
Body weight 
increase (g) in 
5-weeks
Final 
Body 
weight (g)
Rat Chow 151 121 : 272
(Normal rats) ± ± ±
2.58 830 868
Corn oil 159 119 C’d 277
(20%) ± ± ±
4.05 3.70 230
Olive oil 155 140 296
(20%) ± ±
5.80 2.73 732
Butter oil 153 138 292
(20%) ± ± ±
5.67 2.25 6.17
Fish oil (10%) 156 106 262
+ ± ± ±
Olive oil (10%) 537 2.45 539
Fish oil (10%) 153 120 273
+ ± ± ±
Butter oil (10%) 238 6.47 7.57
Statistically significance was determined by one-way Anova and Duncan’s test. Letters 
refer to significance at P <0.05 level, ‘a’ rat chow, ‘b’ com oil, ‘c’ olive oil, ‘d’ butter oil, 
‘e’ fish oil + olive oil and T  fish oil + butter oil. Six rats were used in each group.
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The results showed that compared with the chow-fed control groups, weight gain of 
the com oil group was similar while it was greater for the olive oil (p=<0.05) and 
butter oil (p=0.07). The addition of fish oil to either the olive oil or butter oil groups 
significantly reduced weight gain compared with the olive oil or butter oil alone. The 
lowest mean value occurred in the fish oil-olive oil group although this was not 
significantly different from either the control or the fish oil butter oil group.
Rats in this experiment received a fixed amount of experimental diet at 7.5g / 
lOOg body weight per day per rat during the first three weeks than 7.0g/100g for the 
remaining two weeks. These amounts were based on the mean values of the measured 
ad lib intakes in experiment-I & II respectively (Tables 3:2 & 3:10). The animals in 
control group received rat chow ad libitum for the whole period.
Body composition:
The influence of the supplemented diets on body composition in terms of 
organ weights (g/lOOg body weights) at 5-weeks is shown in table 3:17. No 
significance dietary effects differences were observed for liver, heart, spleen or 
kidney weights. However, the olive oil and especially the butter oil diets produced a 
significantly higher fat pad weight compared to rat chow and com oil groups while the 
olive oil and fish oil induced significant lowering of fat (perirenal fat, mesentric fat 
and epididymal fat pads)pad weights in the respective olive oil and butter oil groups. 
Thus the total fat pad changes reflected the body weight changes implying that 
differences in dietary fatness contributed to the different weight gains.
7 1
Table 3:17 Mean organ weights (g/lOOg body weight) of rats fed with rat chow, corn oil 
(2 0 %), olive oil (2 0 %), butter oil (2 0 %), fish oil (10%)+ olive oil (1 0%) and fish oil 
(10%) + butter oil (10%) for the period of 5-weeks. (Mean ± S.E.)
Groups
Body Composition (g/lOOg body weight)
Liver Heart Kidney Spleen Total fat
(Perirenal fat, 
mesentric fat and 
epididymal fat 
pads)
Rat chow 4.01 0.51 037 0.42 1.62 b'C'd
± ± ± ± ±
0.21 0.10 0.06 0.08 0.15
Corn oil 338 0.40 0.81 0.50 2.16='"''
( 2 0 % ) ± ± ± ± ±
0.21 0.02 0.03 0.03 0.07
Olive oil ■ 3.64 0.41 0.75 0.50 2.46 =-'
( 2 0 % ) ifc ± ± ± ±
0.11 0.03 0.03 0.03 0.15
Butter oil 3.60 0.43 036 0.45 2.70 =’*’’''^
( 2 0 % ) ± ± ih ± db
0.13 0.02 0.05 0.08 0.26
Fish oil (10%) 3.73 0.42 0.77 0.56 1.78
+ ±- ± ± ± ±
Olive oil (10%) 0.07 0.01 0.02 0.05 0.12
Fish oil (10%) 3.71 0.42 0.78 0.44 2.06"
+ ± ± ± ± ±
Butter oil (10%) 0.10 0.02 0.01 0.05 0.12
Statistically significance was determined by one-way Anova and Duncan’s test. Letters 
refers to significance at P <0.05 level, ‘a’ rat chow, ‘b’ com oil, ‘c’ olive oil, ‘d’ butter oil, 
‘e’ fish oil + olive oil and ‘f  fish oil + butter oil. Six rats were used in each group.
Glucose decay curves and insulin response:
The mean changes in the plasma glucose disappearanee patterns after the intra- 
arterial glucose in the rats fed the various diets for the period of 5-weeks is shown in 
fig 3:5 and Table 3:18. After the glucose load (50 mg/100 g body weight, i.a.), the 
plasma glucose levels reached their highest peak at 3 min. in all groups falling rapidly 
after that time. The glucose disappearance between 3 & 15 min was slower (21%  
fall) with the butter oil diet group compared with all other groups which were 
generally similar (37-38% fall).
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Fig 3:5 Glucose tolerance curves at minutes 0^ ^ ^ , 12 and 15 of rats fed with rat chow 
(RC), 20% Com ofl (CO), 20% OKve ofl (OO), 20% Butter ofl (BO), 10% Fish 
oil 4 -10% OKve ofl (FOO) and 10% Fish ofl 4 -10% Butter ofl (FBO) diets for a 
period of 5 weeks.
Table 3:18 Plasma glucose concentrations (mMole/L, data of above curves) at minutes 
0,3,6,9,12 and 15 of rat after the first base-Kne sample a glucose load of 
50mg/10(% body weig i^t i.v. was given. Data are Mean ±  S.E. of 6 rats in each 
group.
Groups O-nrin 3-min 6-min 9-min 12-min 15-min
Rat chow 9.20 21.77 19.65 17.54 15.63 13.92 “
± ± ± ± ± ±
1 0.45 0.65 0.51 0.45 0.45 0.47
1 Cora oil 9.65 22.41 19.15 17.09 15.38 13.86
(20%) ± ± ± db ± ±
1 0.86 0.82 0.75 0.73 0.63 0.73
OKve ofl 8.53 21.69 18.86 17.09 15.38 13.65 “
(20%) db db ±
0.71 0.77 0.68 0.68 0.60 0.48
Butter ofl 10.23 20.72 19.25 18.17 17.11 16.31
(20%) d: ± ± ±
1 0.60 0.56 0.49 0.38 0.45 0.49
Fish oil (10%) 9.32 22.33 19.79 17.74 15.95 14.06“
1 ± ± ± ± ±j OKve ml (10%) 0.37 0.45 0.31 0.24 0.17 0.13
Fish oil (10%) 9.98 22.13 20.09 18.10 16.20 14.28 “
+ ± ± ± ± ±
1 Butter ofl (10%) 0.18 0.35 0.29 0.39 0.36 0.35
Statistically significance was 2q>plied only at 15-min glucose conœntratiotis by one-way 
ANOVA AND Duncan's test.
Letters refer to significance at P < 0.05 level, ‘a’ rat chow, b' com oil, ‘c’ olive oil, ‘d’ 
butter oil, ‘e’ fish oil + olive oil and ‘f  fish oil + butter oil.
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Fig 3:6 Plasma insulm levels at minutes 0, 3, 6, 9 ,12  and 15 of rats fed with with rat 
chow (RC), 20% Com ofl (CO), 20% OKve ofl (OO), 20% Butter ofl (BO), 10% 
Fish oil + 10% Ohve oil (FOO) and 10% Fish oil + 10% Butter oil (FBO) diets 
for a period of 5 weeks.
Table 3:19 Plasma insulin concentrations (pü/nd, data of above curves) at minutes 0 ,3 ,6 ,9 ,  
12, and 15 of rat after the first base-line sanoqple a glucose load of 50mg/100 g body 
weight i.v. was given. Data are Mean ±  S.E. of 6 rats in each group.
Groups 0-min 3-mm 6-min 9-min 12-min 15-min
Control 31.8 54.6 56.4 62.5 69.5 81.3
(Rat chow) ifc ± ± ± db db
2.50 2.23 3.83 5.54 8.79 10,77
Cora ofl 31.9 54.4 54.8 55.8 65.1 67 6 '
(20%) ± ± ± ± ± ±
1.32 1.89 2.38 1.82 6.11 4.61
Olive ofl 28.3 51.4 52.3 51.9 56.5 606*
(20%) ± ± ± ± ±
1.72 0.46 1.14 2.03 3.25 3.88
Butter ofl 37.3 59.8 57.1 63.7 75.5 ÇÇ Ç b ,c ,e ,f
(20%) ± ± ± ± db ±
2.22 3.30 2.76 4.43 5.80 3.53
Fish ofl (10%) 26.4 53.4 51.5 53.9 56.9 59.2'
+ ± ± ± ± ± ±
Ohveofl(10%) 1.32 277 1.56 2.66 3.59 3.95
Fish oil (10%) 30.3 53.3 51.9 59.8 64.6 69 5 '
+ ± ± ± ± ± ±
Butter ofl 10%) 2.75 4.42 4.03 277 2.50 3.06
B s B S B m B s s ta o B M S s a f i
Statistically significance was applied only at 15-min insulin concmtrations by one-way 
ANOVA and Dunce s test
Letters refer to significance at P <0.05 level, ‘a’ rat chow, ‘b’ com oil, ‘c’ olive oil, ‘d’ 
butter oil, ‘e’ fish oil + olive oil and ‘f  fish oil + butter oil.
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The mean changes in plasma insulin levels after the glucose load are showed 
in Table 3:16. In all dietary groups the insulin levels continued to increase over the 
15 minutes although the initial rate of rise slower between 3-9 minutes. The highest 
insulin levels were observed in the butter oil group with an increase from 37.2 ± 2.2 to 
100 ± 3.5 followed by Fish oil + Butter oil (30.3 ± 2.8 to 69.5 ±3.1), Com oil (31.9 ±
1.3 to 67.6 ± 4.6), Olive oil (28.3 ± 1.7 to 60.6 ± 3.9) and Fish oil + Olive oil (26.4 ±
1.3 to 59.2 ± 4.0). The lowest increase in insulin was observed with the olive oil and 
fish oil and olive oil alone groups (Table 3:19).
Glucose intolerance and insulin sensitivity:
No significant dietary effects were found for mean fasting glucose levels. 
However in terms of mean values there were similar fasting insulin levels in the 
control, com oil and olive oil diets with a higher level in the butter oil diet. The fish 
oil with olive oil diet had no effect on the level observed with the olive oil diet but 
when fed with butter oil it lowered the insulin level observed with the butter oil diet 
alone. The glucose disappearance rate (k-value) was similar in all groups apart from 
the butter oil group where it was significantly lowered (P<0.001).
The insulin area under the curve (AUC) after 15 minutes was significantly 
elevated in the butter oil group compared with the lowest values observed in the olive 
oil and fish oil + olive oil (1:1), diet groups respectively. The insulin sensitivity (k- 
value/AUC) was similar in all groups apart from the butter oil group where it was 
markedly lower (Table 3:20).
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Table 3:20 Mean fasting glucose, fasting insulin, glucose disappearance rate (k-value) insulin 
area under the curve (AUC) and insulin sensitivity in rats with rat chow, corn oil 20%, 
olive oil 2 0 %, butter oil 2 0 %, fish oil 10% + olive oil 1 0% and fish oil + butter oil 10% 
for the period of 5-weeks. (Mean ± S.E.)
Groups
Fasting
glucose
(mMole/1)
Fasting
insulin
(uU/ml)
K-value
(%/min)
Insulin 
area under 
the curve 
(AUC)
Insulin
sensitivity
(k-value/
AUCx103)
Control 9.20 31.8 3.75 d 903 4.25 d
(Rat chow) ± ± ± ± ±
0.45 2.50 0.27 723 0.37
Corn oil 9.65 31.9 e 3.96 d 837 4.77 d
(20%) ± ± ± ± ±
Oj# 1.32 0.25 41.6 0.36
Olive oil 8^3 28.3 d 3.77 d 770 d 4.90 d -
(20%) ± ± ± ± ±
0.71 1.72 0.26 24.7 0.30
Butter oil 10.23 37.3 c,e 1.99 a,b,c,e,f 974 c,e 2.07 a,b,c,e,f
(2 0 %) ± ± ' ± ± ±
0.60 2 J 2 0.13 53.1 0.15
Fish oil (10%) 9.32 26.4 h,d 3.79 d 775 d 4.91 d
+ ± ± ± ± ±
Olive oil (10%) 0.37 1.32 0.19 353 0.19
Fish oil (10%) 9j# 30.3 3.65 d 838 4.36 d
+ ± ± ± ± ±
Butter oil (10%) 0.18 2.75 0.17 33.1 0.16
Statistically significance was determined by one-way Anova and Duncan’s test. Letters refer 
to significance at P <0.05 level, ‘a’ rat chow, ‘b’ com oil, ‘c’ olive oil, ‘d’ butter oil, ‘e’ fish 
oil + olive oil and T  fish oil + butter oil. Six rats were used in each group.
Insulinogenic index:
The ratio of plasma insulin to glucose concentrations are shown in table 3:21.
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Table 3:21 Insulinogenic index (insulin/glucose) at minutes 0,3,6,9,12 and 15 of rats
fed with 20% corn oil, olive oil, butter oil or 10% fish oil with 10% olive oil and
10% fish oil with 10% butter oil for a period of 5 weeks.
Groups 0 -min 3-min 6 -min 9-min 1 2 -min 15-min
3.47 2.51 287 256 4.56 282
Control ± ± ± ± ± ±
(Rat chow) 0.25 0 .1 0 0 .2 0 0.30 0.56 0.74
3.43 2.40 :289 229 4.29 4.94“
Corn oil ± ± ± ± ± ±
(2 0 %) 0.29 0.14 0.18 0.18 0.49 0.44
3.40 238 279 3.05 3.67 4.46'
Olive oil ± ± ± ± ± ±
(2 0 %) 0.30 0.08 0.08 0.09 0.16 229
3.67 :288 2.97 3.50 4.41 6.14
Butter oil •± ± ± " ± ± ±
(2 0 %) 0 .2 0 0 .1 2 0.14 ().23 0.32 0.23
Fish oil (10%) 284 238 2.61 3.03 256 4.21 '
+ ± ± ± ± ± ±
Olive oil (10%) 0.14 0.09 0.09 0.14 2 2 2 229
Fish oil (10%) 3.05 2.41 258 232 4.00 4.89'
+ ± ± ± ± ± ±
Butter oil (10%) 0.30 0.21 0 .1 0 0.19 0 .2 2 0.29
Statistically significance was applied only at 15 min ratio by one-way ANOVA and Duncan’s 
test where P<0.05. ‘a’ com oil, ‘b’ olive oil, ‘c’ butter oil, ‘d’ fish oil + olive oil (1:1) and ‘e’ 
fish oil + butter oil (1:1). Six rats were used in each group.
The insulinogenic index tended to be highest in the control and butter oil 
group, in the latter case significantly so compared with the com oil, olive oil and the 
two fish oil groups.
Dietary effects on membrane fatty acids:
The fatty acid composition of hepatic cell membranes isolated from rats in this 
experiment is given in table 3:22. The overall pattem in the control group was most 
comparable to the com oil group in terms of total SFA and SFA/PUFA although the 
n6/n3 ratio was higher (26 control, 17 com oil). The expected pattems were found in 
the various dietary groups, i.e. high linoleic in com oil, high oleic in olive oil, high 
SFA in butter oil and a low n6/n3 ratio in the two fish oil groups The total saturated
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fatty acids were highest (53%) in the butter oil and lowest (37% ) in the fish oil + 
olive oil groups with similar levels in the other groups (40-44%). Total 
polyunsaturated fatty acids (PUTA) were highest in the com oil (42%) and fish oil- 
olive oil group (42%) and lowest in the butter oil diet group (24%). The lowest 
PUFA/SFA ratio was seen in the butter oil group (0.5) with the highest ratio in the 
fish oil olive oil group (1.1). The fish oil groups were the only groups with more 
than 2% n-3 PUFA (at 20-21% in each case) and because of this and the lower total n6 
PUFA levels the n-6/n-3 PUFA ratios were much lower at 1 compared with values 
ranging from 12(butter oil) to 60(olive oil) in the other groups.
Laurie acid (C l2:0) was detected as trace in control, com oil and butter oil 
groups as 2.56% 0.81% and 1.24% respectively. Myristic acid (C14:0) found 1.05% 
in butter oil, 0.87% in com oil and 0.41% in control animals. Palmitic acid (016:0) 
and stearic acid (C l8:0) were found highest in butter oil diet supplemented group, as 
24% and 26% respectively. 27.54% of oleic acid (C l8:1) was detected as highest 
concentration in olive oil and lowest (15%) in com oil diets fed groups. Linolic acid 
(C l8:2) and eicosanoic acid (C20:l) were found highest in com oil diet fed group as 
23.70% and 2.31% respectively. Eicosapentaenoic (C20:5) and docosatetraenoic 
(C22:4) acids were detected only in fish oil supplemented dietary groups. 
Docosadienoic acid was detected in control and fish oil fed rats. Docosahexaeneoic 
(22:6) acid was not detected in com oil and olive oil groups and the highest level 14% 
was seen in fish oil + butter oil group.
J
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Table 3:22 Percentage fatty acids composition of the hepatic cell membrane of rats
supplemented with 20% corn oil, 20% olive oil, 20% butter oil, 10% fish + 10%
olive oil and 10% fish oil +10%  butter oil for the period of 5-weeks.
C-Number
Control 
(Rat chow)
Corn oil 
(20%)
Olive oil 
(20%)
Butter oil 
(20%)
Fish oil (10%)
+
Olive oil (10%)
Fish oil (10%) 
+
Butter oil 
(10%)
C12:0 2 .5 6  
(2 .3 0 , 2 .8 2 )
0.81 
(0 .6 3 , 0 .9 9 )
- 1.24 
(1 .1 0 , 1 .38)
- -
C14:0 0.41 
(0 .3 9 , 0 .4 3 )
0 .87  
(0 .9 8 , 0 .7 6 )
- 1.05
(1 .2 3 ,0 .8 7 )
- 0.81
(0 .8 7 ,0 .7 5 )
C16:0 2 0 .7  
(2 1 .8 , 19 .6)
21.1 
(2 2 .9 , 19 .3)
18.8 
(1 6 .8 , 2 0 .8 )
24.1 
(2 2 .5 ,2 5 .7 )
17.2 
(1 5 .7 , 18 .7)
19.8 
(1 8 .7 , 2 0 .9 0 )
C18:0 19.8 
(1 8 .7 , 2 0 .9 )
20 .5
(1 8 .3 ,2 2 .7 )
2 2 .0  
(2 3 .4 ,2 0 .6 )
26.1 
(2 7 .8 ,2 4 .4 )
19.8 
(2 1 .3 , 18.3)
22 .9  
(2 3 .8 , 2 2 .0 )
N-9
C18:l
19.2 
(17.5, 20.9)
15.2 
(1 4 .7 , 15 .7)
27 .5  
(2 8 .3 , 2 6 .7 )
23.3  
(2 2 .0 ,2 4 .6 )
2 1 .0  
(1 9 .7 , 2 2 .3 )
2 1 .5  
(2 2 .4 ,2 0 .6 )
N-6
C18:2
12.2 
(1 4 .0 , 10.4)
23 .7  
(2 1 .7 , 2 5 .5 )
9.81 
(1 0 .7 , 8 .92)
639  
(7.93, 5.85)
9.11 
(1 0 .7 , 7 .5 2 )
5.11 
(4 .6 2 , 5 .6 0 )
N-3
C20:l
0 .5 4  
(0 .4 3 , 0 .6 5 )
2.31 
(3 .0 2 , 1.60)
0 .52  
(0 .4 8 , 0 .5 6 )
0 .87  
(0 .7 2 , 1.02)
1.01 
(0 .8 6 , 1 .16)
-
N-6
C20:4
2 3 .2  
(23.8, 22.6)
15.5 
(1 4 .8 , 16 .2)
2 1 .4  
(2 0 .4 ,2 2 .4 )
15.4 
(1 5 .2 ,1 5 .6 )
9 .05  
(9.02, 9.08)
11.1 
(1 0 .0 , 12 .2)
N-3
C20:5
- - - - 83#  
(8.21, 9.77)
633  
(7.21, 6.35)
N-6
C22:2
0 .58  
(0 .3 2 , 0 .8 4 )
- - 1.99 
(1 .4 5 , 2 .5 3 )
-
N-6
C22:4
■ - - . . . 1.45 
(2.02, 0.88)
1.72
(2.12, 1.32)
N-3
C22:6
033
(0 .7 3 , 0 .9 3 )
- - 1.03 
(1 .4 7 , 0 .5 9 )
10.4
(1 1 .0 4 ,9 .7 6 )
10.2 
(1 0 .3 , 10 .2)
Total
SFA
43 .5  
(43.2, 43.8)
. 4 3 .3  
(4 2 .8 ,4 3 .8 )
4 0 .8
(4 0 .2 ,4 1 .4 )
52 .5  
(5 2 .6 , 5 2 .4 )
3 7 .0  : 
(3 7 .0 , 3 7 .0 )
43 .5  
( 4 3 .4 ,4 3 .6 )
Total
PUFA
37 .4  
(39.3, 35.4)
41 .5  
(3 9 .5 ,4 3 .3 )
3 1 .7
(3 1 .6 ,3 1 .9 )
2 4 .2
(2 5 .3 ,2 3 .1 )
4 2 .0  
(4 3 .3 ,4 0 .7 )
34 .9  
(34.3, 35.8)
PUFA/SFA
ratio
036
(0 .9 1 ,0 .8 1 )
0 .96  
(0 .9 2 , 0 .9 9 )
0 .78  
(0 .7 9 , 0 .7 7 )
0 .46  
(0 .4 8 , 0 .4 4 )
1.14 
(1 .1 7 , 1.10)
0 .8
(0 .7 9 , 0 .8 2 )
PUFA/MUFA
Ratio
1.95 
(2 .2 5 , 1 .69)
2 .73  
(2 .6 9 ,2 .7 6 )
1.15 
(1 .1 2 , 1.19)
1.04 
(1 .1 5 , 0 .9 4 )
2 .0 0
(2 .2 0 ,1 .8 2 )
1.62 
(1 .5 3 , 1.74)
N-3 1.37 
(1 .1 6 , 1 .58)
2.31 
(3 .0 2 , 1.60)
0 .52  
(0 .4 8 , 0 .5 6 )
1 .90 
(2 .1 9 , 1.61)
2 0 .4
( 2 0 .1 ,2 0 .7 )
17.0 
(1 7 .5 , 16 .6)
N-6 3 6 .0  
(38.1, 33.8)
393
(3 6 .5 , 4 1 .7 )
31 .2
(3 1 .1 ,3 1 .3 )
22.3
(2 3 .1 ,2 1 .5 )
2 1 .6  
(2 3 .2 , 2 0 .0 )
17.9 
(1 6 .7 , 19 .1)
N-6/N-3
ratio
2&3
( 3 2 .8 ,2 1 .4 )
17.0 
(1 2 .1 , 2 6 .1 )
6 0 .0
# 4 3 , 55.9)
11.7
(1 0 .5 ,1 3 .4 )
1.06
(1 .1 5 ,0 .9 7 )
1.05 
(0 .9 5 , 1 .15)
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Table 3:23 Percentage fatty acids composition of the erythrocytes membrane of rats
supplemented with 20% corn oil, 20% olive oil, 20% butter oil, 10% fish +
10% olive oil and 10% fish oil +10% butter oil for the period of 5-weeks.
C-Number
Control 
(Rat cbow)
Corn oil 
. (20%)
Olive oil 
(20%)
Butter oil 
(20%)
Fisb oil (10%
+
Olive oil (10%)
Fish oil (10%)
+
Butter oil 
(10%)
C12:0 2.79
(2.43,3.15)
2.53 
(2.85,2.21)
- 1.76 
(0.96, 2.56)
- -
C14:0 038 0.78 0.32 0.97 0.44 0.32
(0.32,0.44) (1.02, 0.54) (0.43,0.21) (1.03,0.91) (0.38, 0.50) (0.28,0.36)
C16:0 20.8 22.5 19.8 30.1 18.5 20.2
(21.51,20.15) (21.6,23.4) (20.4,19.2) (28.8,31.4) (17.8, 19.2) (19.3,21.1)
C18:0 19.9 19.6 20.8 24.0 21.9 19.7
(18.27,21.55) (20.2,19.1) (19.9,21.7) (25.7,22.3) (22.8,21.0) (21.2,18.2)
N-9 16.1 19.5 27.7 21.8 19.6 20.1
C18:l (15.81, 16.37) (20.2, 18.8) (28.4,26.9) (22.3,21.3) (20.5, 18.7) (18.9,21.3)
N-6 13.5 22.2 9.20 7.3 7.84 8J
C18:2 (15.15, 11.87) (21.5, 23.0) (10.1, 8.3) (6.80, 7.80) (6.39,9.29) (9.56,6.84)
N-3 0.69 1.20 0.70 1.21 0.94 0.36
C20:l (0.62,0.76) (1.54,0.86) (0.70, 0.70) (1.04, 1.38) (0.90, 0.98) (0.36, 0.35)
N-6 2Z89 11.6 21.5 10.2 8^2 10.5
C20:4 (22.07, 23.71) (11.1,12.1) (20.1,22.9) (10.6, 9.80) (10.1,6.34) (9.18,11.8)
N-3
C20:5
- - 6.87 
(6.34, 7.40)
6.18 
(6.49, 5.87)
N-6
C22:2
1.00 
(1.47, 0.53) (-,-)
- - 0.67
(0.53,0.81)
0.40 
(0.48,0.32)
N-6
C22:4
0.35 
(0.52, 0.18)
- - 2.39 
(3.48, 1.23)
-
N-3 1.56 2.70 12.7 14.0
C22:6 (1.83, 1.29 (2.80,2.60) (10.85, 14.48) (14.2, 13.8)
Total 43.9 45.4 40.9 56.8 40.8 40.2
SFA (42.6,45.4) (45.7,45.3) (40.7,41.1) (56.5, 57.2) (41.0,41.7) (40.8, 39.7)
Total 40.0 35.0 31.4 21.4 3&6 39.6
PUFA (41.7,38.4) (34.1,36.0) (30.9,31.9) (21.2,21.6) (38.6, 40.5) (40.3, 39.0)
PUFA/SFA 0.91 0.77 0.77 0.38 0.97 0#8
ratio (0.98, 0.85) (0.75, 0.79) (0.76, 0.78) (0.38,0.38) (0.94, 0.97) (0.99, 0.98)
PUFA/MUFA 2.48 1.79 1.13 0.98 2.02 1.97
Ratio (2.64, 2.34) (1.69, 1.91) (1.09,1.19) (0.95, 1.01) (1.88,2.17) (2.13, 1.83)
N-3 2.25 1.2 0.70 3.91 20.5 20.5
(2.45, 2.05) (1.54, 0.86) (0.70, 0.70) (3.84,3.98) (1.88, 22.9) (21.1,20.0)
N-6 37.7 318 30.7 17.5 19.1 19.1
(39.3,36.1) (32.6, 35.1) (30.2,31.2) (17.4, 17.6) (20.5, 17.7) (19.2. 19.0)
N-6/N-3 16.8 28.2 43.9 4.48 0.93 0.93
ratio (16.0, 17.6) (21.2,40.8) (43.1,44.6) (4.53,4.42) (1.13,0.77) (0.91,0.95)
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The fatty acid composition of erythrocyte membrane lipids in these studies is given in table 
3:23. The overall fatty acid profiles are similar to those observed in the hepatic membrane 
lipids with the exception that in the butter oil group the slightly lower n-6 PUFA and higher n-3 
PUFA means that the n6/n3 ratio was lower at 4.48 compared with 11.7 in the hepatic lipids.
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CHAPTER IV 
DISCUSSION
A high intake of dietary fat has been implicated in the aetiology of insulin 
resistance (Swinbum, 1993), a major metabolic disorder of NIDDM and obesity. The 
high-fat-fed rat model of insulin resistance has been used extensively to elucidate 
physiological mechanisms of non-pharmacological (Kraegen et al, 1989; Storlien et 
al, 1991) and pharmacological strategies (Storlien et al, 1993; Oakes et al, 1994) for 
reversing or preventing insulin resistance. An elevated level of circulating free fatty 
acids in obesity is believed to play a potential role in causing insulin resistance. It has 
been reported that the increased portal free fatty acids flux reduce hepatic insulin 
binding and extraction, thereby resulting in hyperinsulinaemia, while the increased 
free fatty acid concentrations can cause impaired suppression of endogenous glucose 
production (gluconeogenesis), which leads to hyperglycaemia. Both 
hyperinsulinaemia and hyperglycaemia may contribute directly, or exacerbate insulin 
resistance.
The main objective of the present studies was to clarify the relative influence 
of dietary fat type on glucose tolerance and insulin sensitivity in male Wistar rats. It 
was assumed that one mechanism would involve an alteration of membrane 
phospholipid composition and that this would influence insulin-mediated glucose 
uptake. Thus membrane phospholipid composition was also measured. It was also 
assumed that changes in glucose tolerance would be related to body fat accumulation
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influencing overall growth rates and body fat content which was monitored through 
measurement of fat pad weight.
Progression o f  the experimental work:
The experimental work described in this thesis developed over time and 
involved changes in methods when recognised as necessary and also involved 
opportunities to participate in a collaborative study. At the start pilot studies were 
performed to establish a satisfactory experimental protocol. The dietary treatment in 
the pilot study involved a relatively high fat diet (20% by weight, 39% energy) 
comprising, com-oil (n-6 PUFA), olive-oil (MUFA), and a combination of fish-oil 
and olive-oil (n-3 PUFA/MUFA ) (1:4) While this pilot provided information about 
food intake, growth and body composition the attempt to establish an intraperitoneal 
route of glucose administration failed. Thus in the subsequent experiment 
(experiment-I) an intra-arterial route of glucose administration was developed and 
utilised successfully. 20% fat diets were again used comprising com oil (20%), olive 
oil (20%), fish oil (4%) + olive oil (16%) and butter oil (20%) fed for 5-weeks, since 
it was recognised that there was a need to include a saturated fat diet as well as the n-6 
and n-3 PUFA and MUFA diets. After this study experiment II was undertaken in 
collaboration with a colleague working on the effects of dietary fat on the metabolic 
response to trauma (Iqbal, 1997). In these studies a lower fat diet was adopted (10% 
by weight, 22% by energy) since high fat diets were not a study objective. Thus 10% 
diets of com oil, olive oil, butter oil and fish oil/olive oil (1:1) were fed for 5-weeks 
and glucose tolerance and insulin sensitivity measured. A further change in this study 
was the use of a RIA assay for insulin rather than the Elisa because of concem for its 
specificity for rat insulin. Because there were differences in the responses of glucose
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tolerance to the dietary fats between the 20% and 10% fat diets it was not possible to 
draw any satisfactory conclusions. Also it was recognised that the interpretation of the 
fish oil effect was difficult to judge given that it was fed with olive oil. For these 
reasons a third experiment was performed to resolve the issue.
This new experiment (experiment-III) involved a 20% fat diet but with the following 
changes in experimental design.
1. Addition of a control group based on chow.
2. Restriction of food intake to a fixed amount for all diets.
3. Inclusion of fish oil fed at a higher level (10%) and with both olive oil
(10%) and butter oil (10%).
4. Insulin assay by RIA not Elisa.
5. Membrane phospholipids were estimated in hepatic cell membranes and
erythrocytes.
The rat model: effects o f dietary fat on growth:
In experiment I (ad lib intakes of 20% fat diets), there were differences in 
outcome in terms of body weight with rats fed the MUFA and SFA diets 
significantly heavier than those fed the n-6 and n-3 PUFA diets. However even 
though the food intake was lowest with the fish oil diet possibly due to a lower 
palatibility and highest with the olive oil group, in line with there relative body 
weight changes, there were no significant differences in food intakes between the 
groups.
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In experiment -II (ad lib intakes of 10% fat diets) there were no significant 
differences in body weight growth (Table 3:6) or food intakes (Table 3:7) between 
the groups and the food intakes were generally comparable to those with the 20% 
fat diet in experiment-1 ).
In experiment-III the rats received fixed amount of food which was calculated 
from the food intake data in experiment I & II at a level which it was assumed 
they would all eat and which would allow near maximal growth. In this case the 
pattem of body weight increase among the dietary groups was the same as in 
experiment-I i.e. the MUFA and SFA groups grew significantly larger compared 
with the n-6 and n-3 PUFA groups while these latter groups grew at the same rate 
as the chow-fed control (Tables 3:1 & 3:13).
Thus whilst the type of dietary fat may possibly influence food intake in the 
rat any effect is small and was not detected in these studies. As for body weight 
growth it does appear that dietary fat can have a small effect although the effect 
depends on the fat level and the type of fat. At 10% fat (22% energy), there is no 
effect of fat type. At 20% (40% energy) there is a reproducible difference between 
high PUFA fats and MUF/SFA fats.
Most previously reported rat studies of body weight changes in rats fed dietary 
various diet fats indicate no marked differences in body weight and growth 
pattems during normal feeding (Besler and Grimble, 1995; Kuratko et al, 1994; 
Parrish et al, 1991), with any differences observed relating to variation in dietary 
caloric density or to the palatability of the diet. Storlien et al, (1991) reported that
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dietary fats (310 kcal/day) fed as saturated, monounsaturated, or polyunsaturated 
fatty acids to adult male Wistar rats did not influence rates of body weight gain 
during the feeding period. Furthermore, Masi et al, (1986) reported that, moderate 
dietary fat intake (10% w/w) with either butter oil, olive oil, or com oil or the 
major dietary lipid fed for a period of 8-weeks did not produce any significant 
change in body weights as compared to a control, chow, diet.
It has been suggested that, for the rat, dietary fat at more than 10% energy 
represents a general metabolic challenge which may result in a depressed appetite 
and food intake and if this was the case it could explain an inconsistent effect of 
dietary fat type on body weight growth. This is certainly indicated by the studies of 
Yaqoob et al, (1995). They reported decreased food intakes in rats after feeding 
high fat diets (20%) of coconut oil, olive oil, safflower oil, evening primrose oil, or 
menhaden (fish) oil fed for 10-weeks compared to groups fed 10% fat diets. 
However in the present studies there were only very small differences in food 
intake between the two levels of fat in the diet (Table 3:2 & 3:7). Thus on a body 
weight basis intakes on the lower fat (10%) diet ranged from 13% more (FO) to 
6% less (0 0 ) compared with the 20% diet (4% more for all groups combined) with 
none of the differences significant (by t-test). Calculating on a metabolic body 
weight basis (g/Kg'^0.75) to take into account the different body weights in the two 
studies, intakes were on average 11% more on the lower fat diet but again none of 
the differences were significant. Furthermore, there was no obvious relationship 
between the pattem of food intake and the pattem of body weight gains in 
experiments I & II where significant difference were observed. This is best 
illustrated by a comparison of the com oil and butter oil fed rats. The lower body
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weight gain of the com oil group was accompanied by a slightly higher mean food 
intake, compared with the butter oil group. Thus if high fat diets do depress food 
intakes the effect is small and not reproducible at least over the periods of 
supplementation in the present studies.
As far as weight gain variation in response to the type of fat is concemed the 
present studies show clear effects as has been previously observed. Cunnane et al, 
(1986) reported that alteration of the dietary fatty acid profile influences several 
metabolic processes, and found to be a determinant of tissue phospholipid fatty 
acid composition and rate of weight gain in rats. Thus with isocaloric feeding, 
weight gain was least in animals fed a more highly saturated diet in combination 
with 18:3 n-3 as compared to either a high n-9 diet or a high n-6 diet, 
supplemented with identical amounts of 18:3 n-3 fat. Rats consuming a fish oil 
diet have been reported to reach lower final body weights compared to other 
dietary fats (Mulrooney and Grimble, 1993). Also Luo et al, (1996) report that 
body weights of rats fed fish oil for 6-weeks were similar to those of rats fed com 
oil, although epididymal adipose tissue weight was lower in fish oil group. 
Furthermore, Macho et al, (1993) reported body weight gain was lower in rats fed a 
fish oil plus high sucose diet than those fed fed a high sucrose diet alone. Pan and 
Storlien, (1993) reported an inverse relationship between weight gain and tissue 
levels of n-3 fatty acids.
Similar responses were seen in the present studies. Thus mean body weights 
were lowest in the fish oil groups in each experiment with significantly lower 
weights compared with the olive oil group in experiments !  and III and compared
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with the butter-oil group in experiment III. The dietary designs employed here do 
not allow a conclusion to be reached as to the relative influence of the n-3 
compared with the n-6 PUFA. Thus growth rates of the com oil and fish oil groups 
did not differ markedly but the fish oil groups involved intakes of both body 
weight lowering (fish oil) and body weight raising fats (olive and butter oil). As far 
as body weight raising diets at the 20% level it is clear that both the MUFA (olive 
oil) and SFA (butter) diets increased body weights to higher weights than observed 
in chow fed control rats. From a metabolic point of view both monounsaturated 
and saturated fat diets favour adiposity by increasing fat deposition, while the 
lowering effects of fish oil consumption on adiposity is well established (Pan et al, 
1994; Parrish et al, 1991). An increased dietary fish oil or long chain PUFA intake 
result in decreased triacylglycerol formation. Also an indirect influence on 
adiposity is also exerted by their effect of increasing the metabolic rates (Parrish et 
al, 1991; Pan et al, 1994). Pan et al, (1994) reported that the body’s ability to 
synthesize saturated and monounsaturated fat and it’s inability to synthesize either 
n-6 or n-3 fat leads to incorporation of the saturated and monounsaturated fatty 
acids into adipose in absence of endogenous fatty acids of n-6 or n-3 family. In 
human studies an inverse relationship was found between the proportion of body 
fat and its content of long chain PUFA in Pima Indians (Storlien et al, 1993). The 
process is possibly controlled by membrane-associated events where competition 
exists between fatty acid classes for the biosynthetic enzymes of elongation and 
desaturation. Increased desaturase and decreased A^  desaturase enzyme activity 
favour higher position of fat (Pan et al, 1994).
In human nutrition whilst it is known that high fat diets generally increase the 
extent of obesity there is relatively little information on the importance of dietary fat 
quality as opposed to concentration. In one study (Sirtori et al, 1986) human subjects 
were fed over a period of 8 weeks with either com oil (45g) or olive oil (45g) per day 
as the major dietary fat. No significant weight changes were recorded during the 
dietary periods as compared to on normal diet subjects or among the dietary groups. 
Clearly in human studies many factors other than a metabolic response to dietary fat 
could influence weight gain during intervention trials.
Effects o f  dietary fa t on body composition:
In these studies measurements of body composition were limited to 
measurement of weights of liver, spleen, kidney and heart to see whether there was 
any change in these organs and to the weight of the epididymal fat pad as a 
measure of the overall body fat content. The main findings were that in all three 
dietary studies the animals fed the MUFA and SFA diets exhibited the higher body 
fat content compared to either n-6 or n-3 PUFA diets. In fact in experiment III the 
inclusion of the control chow fed group shows that all 20% fat experimental diets 
increased adiposity with the exception of the fish oil-olive oil group. These 
changes in fat pad mass indicate that the increased body weights induced by the 
MUFA and SFA diets involved increased adiposity (Tables 3:1, 3:6 & 3:13) in all 
the three experiments (Expt-I, Expt-II and Expt-III). As far as fish oil is concerned, 
each fish oil enriched diet fed with either MUFA (1:4 or 1:1) or with SFA (1:1), 
produced significantly smaller epididymal fat pads and by implication lower body 
fat content, compared with diets rich in MUFA or SFA.
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Previous studies have also reported significantly lower fat pad size in fish oil fed 
rats compared to rats consuming saturated animal fat (Parrish et al, 1991). Hill et al, 
(1993) also demonstrated that rats fed fish oil has less total body fat and less intra­
abdominal fat with a similar body weight compared with rats fat fed lard, com oil or 
medium-chain triacylglycerols. However, Lou et al, (1996) reported that fish oil fed 
rats significantly decreased the epididymal fat pads as compared to com oil fed rats 
for 6-weeks. Our results also show this because in expt 111 that fat pad size in the fish 
oil-olive oil group was significantly lower than in the com oil group.
However, where differences in weight gain occurred (experiment 11) these were not 
entirely a result of altered adipose tissue content. Thus heart weight was significantly 
reduced by the n-3 PUFA diet group (Expt. 1) and kidney weight was increased 
significantly in the com-oil diet fed rats (Expt. 11). Several workers have reported 
different influences of dietary fat on organ weights. Thus weanling male rats fed for 
10 weeks on a control low fat diet were compared with one of five high fat diets 
containing 20% by weight of either coconut oil, olive oil, safflower oil, evening 
primrose oil or menhaden (fish) oil. In this case the fish oil diet, but not any other, 
resulted in greatly increased liver weight compared with each of the other diets 
(Yaqoob et al, 1995). Lu and Wu, (1994) fed 10% fat diets low in MUFA or high in 
MUFA with or without 1% cholesterol for 4 weeks to weanling (28 days) male 
Sprague-Dawley rats and showed that body weight gain, food efficiency, and liver 
weight were comparable among the groups except for an increase in liver weight 
induced by the dietary cholesterol. Taken together these reports and our results
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indicate that whilst dietary fat quality can influence food intake weight gain and 
degree of adiposity, influences on relative organ growth are small.
Dietary fa t and glucose tolerance:
Hyperglycaemia and glucose intolerance due either to insulin deficiency or to 
impaired effectiveness of insulin action are common defining features of diabetes 
mellitus which is otherwise defined as an etiologically and clinically heterogeneous 
group of disorders. The first abnormality that can be detected in adult onset or non­
insulin dependent diabetes mellitus (NIDDM) is insulin resistance, although both 
insulin resistance and impaired (3-cell function appear to be essential for full 
expression of the disease (DeFronzo and Fersannini, 1992). Evidence suggests that 
insulin resistance develops in genetically predisposed individuals in response to 
environmental triggers (Barnett et al, 1981). The environmental factors responsible 
for the onset of the disease are not well characterized but may include the type of fat 
and/or carbohydrate in the diet (Storlien et al, 1993) or the degree of obesity of the 
individual, as judged by body mass index (Scarfors et al, 1991).
The development of glucose intolerance and insulin resistance is difficult to 
study in human populations because it develops progressively primarily during middle 
age (DeFronzo and Fersannini, 1992). The aetiology of insulin resistance may be 
heterogeneous (Olefsky, 1993), and it often goes undiagnosed until it reaches and 
advanced stage. In fact diagnostic criteria are defined for NIDDM rather than for 
insulin resistance per se (Jarrett, 1989). Nevertheless, diet is considered an important
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environmental factor influencing insulin sensitivity (Bogardus et al, 1986) and it is 
well known that, high carbohydrate intake has significant affects on insulin secretory 
capacity, and glucose tolerance (Himsworth, 1935). High carbohydrate diets 
improves the carbohydrate economy by enhancing peripheral sensitivity to insulin 
(Fukagawa et al, 1990; Grimditch et al, 1988), lowering fasting glucose (Villaume et 
al, 1984). Such diets also lower low density lipoprotein cholesterol (Borkman et al, 
1991) in diabetic patients as well as in normal subjects (Grundy, 1986).
Glucose intolerance and insulin resistance can be readily induced and studied 
in animals. The most widely used animal model of insulin resistance is the high fat- 
fed rat (Storlien et al, 1986). Insulin resistance develops in as little as 4 days of high 
fat feeding. High fat feeding with com oil in rats has been reported to develop in vivo 
and m vitro insulin resistance and impaired glucose tolerance (Wiersma et al, 1993). 
Harris et al, (1992) reported that a moderate reduction in fat intake from 40% to 30% 
of energy can produce a rapid improvement of insulin sensitivity in insulin-insensitive 
rats. Clearly this does not accurately mimic the human condition since insulin 
resistance appears to develop over a much longer time span. Most importantly the 
degree of insulin resistance and impaired glucose tolerance induced by high fat 
feeding is highly dependent on the type of fat given (Wiersma et al, 1993).
Saturated fatty acid rich diets are known to cause impaired glucose tolerance 
and increase insulin resistance compared to polyunsaturated fatty acids (Pan et al, 
1994). Feeding period and the level of fat has also been reported to influence glucose 
tolerance in rat studies. Feeding a 40% com oil diet caused a lower rate of glucose 
disappearance in rats compared to a glucose or a chow diet (Ramirez et al, 1990),
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whilst a longer feeding period resulted in a gradual deterioration of glucose tolerance 
in rats consuming a 30% com oil (Wiersma et al, 1993).
In the present study it was clear that fasting glucose levels was not indicative 
of glucose tolerance since no significant dietary effects were observed in any 
experiment. However three sets of data on glucose tolerance were obtained as the 
fractional glucose disappearance rate after an intravenous glucose tolerance test 
(Table 4:1).
Table 4.1 Glucose tolerance (K-value): experiments I, II,HI.
K-value K-value K-value
Groups (%/min) (%/min) (%/min)
Dietary fat level Experiment I (20%) Experiment II (10%) Experiment III (20%)
3.75“
Control — ±
(Rat chow) 0.27
5.37“ 3.54 3 .96“
Corn oil ± ± ±
0.22 0.30 0.25
2.77“’“ 4.03 ' 3.77“
Olive oil ± ± ±
0.39 0.28 0.26
4.81 2.94 J  p p  a,D,c,e,i
Butter oil ± ± ±
1.02 0.20 0.13
Fish oiFolive oil (1:4) Fish oil/olive oil (1:1) Fish oiFolive oil (1:1)
Fish oil/olive oil 7 .32“ 3.96" 3.79“
± ± ±
1.31 0.39 0.19
Fish oil/butter oil (1:1)
Fish oil/butter oil 3.65 “ 
± 
0.17
Statistical significance was determined by one-way ANOVA and Duncan’s test where 
P<0.05. Six rats were used in each group.
Experiments I & II. ‘a’ com oil, ‘b’ olive oil, ‘c’ butter oil and ‘d’ fish oil/olive oil 
Experiment III. ‘a’ rat chow, ‘b’ com oil, ‘c’ olive oil, ‘d’ butter oil, ‘e’ fish oil/olive oil 
and T  fish oil/butter oil.
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In experiment 1 glucose tolerance was lower in the SFA and MUFA diet 
groups compared with the n-6 and n-3 PUFA/MUFA diets (which were not 
different). Whilst the impairment by the SFA was consistent with previous data, 
the surprising and unexpected feature of this set of data was the impairment with 
the MUFA diet. This implies that fish oil can have a marked effect on improving 
what would be an impaired glucose tolerance due to olive oil. However in 
experiment II with the fats fed at 10%, although the impairment by the SFA diet 
was seen again, in this case the MUFA diet maintained glucose tolerance with a 
significantly higher Kgiucose value than with the SFA diet and with a similar value 
for the two PUFA diets. The third experiment was designed to resolve these 
differences as far as the MUFA diet was concerned as well as a) establishing a 
control value with a chow diet and b) feeding diets involving n-3 PUFA fed with 
both MUFA and SFA to establish unequivocally the effect of fish oil. The results 
this time were quite clear. Compared with the control, the only high fat diet to 
impair glucose tolerance was the SFA diet and when this was fed with fish oil the 
impairment was reversed. Furthermore when values in expts II and III were 
compared to establish if the higher fat diet had any extra impact compared with the 
10% diet it was clear that a) at 10% the Kgiucose value for the SFA group (2.94+0.5) 
was significantly lower than the chow fed control in experiment III (3.74+0.66 
p=0.04), and that b) the higher intake of the SFA worsened glucose tolerance 
significantly (1.99+0.31) compared with SFA at 10% (p=<0.01). The Kgiucose 
values with the MUFA and PUFA diets did not vary with the level of fat fed. Thus 
it appears that the results in experiment I could not be reproduced as far as the 
MUFA diet was concerned although there is no obvious reason why they should
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be discrepant. For the rest of this discussion the results of experiment II and III will 
be taken as representative of the true effect of dietary fat on GTT in the rat: i.e. 
SFA as a butter oil diet progressively worsens glucose tolerance, an effect which 
can be reversed or prevented when fish oil is fed with the SFA.
Recent human studies which have studied the influences of dietary saturated 
and monounsaturated fat on glucose homeostasis are consistent with the present 
findings. Thus butter (lOOg) was shown to decrease the glucose disposal rate the 
blood glucose response area in subjects with NIDDM while neither 40g nor 80g 
olive oil had any influence on the glucose response (Rasmussen et al, 1996). 
Addition of 35g of com oil or olive oil to a starch-rich meal reduced the glycémie 
response area in normal subjects by 70%, while no effect on postprandial blood 
glucose response area was observed after adding 35g of saturated fat (butter) to the 
same meal (Gatti et al, 1992). Nydahl et al (1995) concluded that, lipid-lowering 
diets containing either rapeseed oil or olive oil, improved the intravenous glucose 
tolerance. Furthermore, Rasmussen and colleagues (1995) confirmed that diets 
rich in monounsaturated fatty acid improved glucose tolerance as compared to high 
carbohydrate diet.
The several reports on diet fat and obesity in both animals (Salmon and Flatt, 
1985; Hill et al, 1989) and humans (Dreon et al, 1988; Miller et al, 1990) have 
demonstrated an association between dietary saturated fat intake and obesity, and 
this is usually taken as suggesting that dietary SFA may worsen glucose tolerance. 
According to Harris and Kor (1992), part of the reason for this is that a high-fat 
diet (59% of energy) promotes obesity by depressing adipocyte lipolysis with 
obesity per se influencing glucose tolerance. However in the present studies this
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would not explain the impairment induced by the SFA diet since the level of 
adiposity as judged by fat pad weight and body weight did not differ between the 
rats fed the MUFA or SFA diets. Other mechanism may involve acute postprandial 
influences. Thus Collier and O’Dea, (1983) showed that the addition of 50g 
(butter) fat to a 50g potato-carbohydrate meal, reduced the postprandial glucose 
response, due to a fat-induced inhibition of gastric emptying. However few studies 
have actually measured the specific influence on glucose tolerance per se. Thus on 
the basis of the present results it would appear that SFA as butter worsens glucose 
tolerance by some mechanism which is independent of the development of 
adiposity.
There is a great deal of interest and some confusion about the influence of n-3 
PUFA on the development of insulin resistance and related metabolic disorders, n- 
3 fatty acid treatment in NIDDM patients have been reported to both worsen 
(Friday, et al, 1989) or not influence fasting glycemia (Kasim et al, 1988; 
Puhakainen, et al., 1995). However it is by no means clear whether the worsening 
of plasma glucose by n-3 fatty acid when observed, is related to the dose 
consumed, the type of patient (e.g., the presence of obesity) or simply due to an 
uncontrolled dietary regimen. Indeed Popp-Snijders et al, (1987) showed glucose 
tolerance was improved (i.e. insulin-stimulated glucose uptake m v/vo was 
increased) by 25% in NIDDM patients after consumption of 3g n-3 PUFA/day for 
8-weeks.
Understanding the influence of fish oil is complicated because in practice fish 
oil is never consumed as the sole source of fat in the human diet. The Greenland
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Eskimos could be taken as an exception, whose traditional diet comprises of 
exceptionally high n-3 fat (Berdanier, 1994). These Eskimos have been reported to 
have normal glucose tolerance and low serum lipid levels when consuming their 
traditional diets. Once switched over to Western diets the Greenland Eskimos have 
shown abnormal glucose tolerance and higher circulating lipids (Feldman et al, 
1975). In the present studies because of concern that a 100% fish oil diet might 
influence food intake through impairing food intake, it was decided to examine the 
influence of fish oil fed with another fat. Thus it was fed initially with a MUFA 
rich fat (olive oil) and in the final experiment with either MUFA or SFA rich diets: 
i.e. as a n-3 PUFA/MUFA mix of either 1:4 (experiment I) or 1:1 (experiment II & 
III) or a n-3 PUFA/SFA mix at the 1:1 (experiment III). Thus any effect of fish oil 
needs to be assessed by comparison with both the chow fed control and with either 
the appropriate MUFA or SFA rich diet. Compared with the chow-fed control 
(experiment III) the fish oil diets fed in either 10% or 20% fat diets (experiments II 
or III) did not influence glucose tolerance. However because the fish oil-butter oil 
diet improved glucose tolerance compared with butter oil alone (p=<0.0001) it can 
be concluded that fish oil has a beneficial effect on glucose tolerance. What is not 
known from the present data however is whether a com oil-butter oil mix would 
have a similar beneficial effect.
The effects of dietary fish oil on glucose homeostasis has been studied by two 
groups in a high fat insulin-resistant rat model (Hainault et al, 1993; Storlien et al,
1987), with somewhat different results. In rats fed a 59% fat diet, Storlien et al,
(1987) investigated the effects of replacing 6% of n-6 PUFA from safflower oil 
with n-3 PUFA from fish-oil. They found that the fish oil diet increased in vivo
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insulin-stimulated glucose metabolism in liver and skeletal muscle but not in white 
adipose tissue. In contrast, Hainault et al, (1993) reported that a 15% fish-oil, 
50% total fat diet did increase insulin-stimulated glucose transport in adipocytes 
in vitro. The discrepancy between the results of these two studies could be related 
to the higher dose of n-3 fatty acids used in the latter study or could be 
methodological. In a third rat study with high fat feeding, (60% fat), Ezaki et al, 
(1992) showed that a 4-week fish-oil supplementation could not correct either the 
insulin-resistance nor the enlargement of adipocytes. In contrast Vrana et al,
(1988), working with a rat model in which insulin resistance and 
hypertriacylglycerolemia were induced by both sucrose and olive-oil, found that 1 
ml of fish-oil supplementation increased insulin-stimulated glucose incorporation 
into adipose tissue lipids compared with 1 ml of olive oil supplementation. No 
information was given in this study about plasma glucose or insulin concentrations. 
However very few previous rat studies have measured actual lAGTT as reported 
here and showed the better LAGTT especially compared with SFA.
Changes in glucose disposal during the lAGTT can result from changes in 
insulin secretion or action and in this study both aspects have been examined in 
terms of fasting insulin, the area under the insulin curve after the glucose injection 
(insulin AUG) and the insulinogenic index, a measure of insulin secretion adjusted 
for glucose concentrations. Insulin action is calculated in terms of the insulin 
sensitivity value i.e. K giucose/insulin AUG.
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Dietary fa t and insulin secretion.
In the current studies the reliable insulin measurements relate to Expt-II (10% 
fat) & III (20% fat) where an RIA assay was used rather than the ELISA in 
experiment I. The responses show clearly that the SFA and MUFA diets were 
associated with the greatest and least hyperinsulinaemia respectively, with the 
nbPUFA tending to be of intermediate influence and with the fish oil significantly 
reducing the hyperinsulinaemic influence of the SFA. These overall patterns can be 
seen in fig 4:1 which shows the distribution of the dietary groups between tertiles 
of fasting insulin, the area under the insulin ivGTT curve (AUC) and the 
insulinogenic index (insulin/glucose ratio) when fed at 10% fat (experiment II) and 
20% fat experiment III.
Fig 4:1 Influence of the dietary fat type and dietary level on insulinaemia.
The chart shows the distribution of each dietary group within tertiles of fasting 
insulin, the area under the insulin ivGTT curve (AUC) and the insulinogenic index 
(insulin/glucose ratio) in experiments II (n=8 per tertile) and III (n=12 per tertile). 
Values shown for each tertile are mean and sd (n=12 experiment III, n=8 
experiment II).
At each dietary level the butter oil (SFA) values were in the top or middle 
tertile range for each insulin parameter and with more in the highest tertile on the 20% 
compared with the 10% fat diet. For olive oil (MUFA) and especially the fish oil/olive 
oil values (nSMUFA) the opposite distribution was observed although in this case 
values were found in all three tertiles. No clear difference is apparent between the fish
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oil/MUFA group and MUFA group alone. In contrast the fish oil/butter oil values 
(n3SFA) on the 20% diet showed a distinct shift to lower tertiles compared with the 
SFA indicating that fish oil ameliorated the hyperinsulinaemic effect of the SFA diet. 
In the 20% fat experiment the addition of the chow-fed groups allows a comparison of 
the high fat diets with this control diet which is supposedly optimised for the rat. In 
fact the control values tended to be more variable than the other groups and were 
distributed between all three tertiles. This meant that none of the groups differed 
significantly from the control groups.
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There are relatively few reports concerning the influence of dietary fat on insulin 
secretion. This data is consistent with the insulinogenic effect of the consumption of 
saturated fat reported in the previous studies of Collier et al, (1988) and Rasmussen et 
al, (1996). The mechanism by which saturated fatty acids increase insulin release is 
not known. However, it has been suggested that SFA appear to potentiate insulin 
release from isolated mouse islets through an increase in intracellular calcium and 
another, as yet unidentified, glucose-dependent mechanism (Wamotte et al, 1994). 
Because fat is the most potent dietary stimulus of gastric inhibitory peptide (GIF) 
(Collier and Dea, 1983), an indirect effect via GIP-mediated glucose-dependent 
insulin secretion might also operate (Sarson et al, 1984).
Supplementation with PUFA’s are reported to exert an augmentation of 
insulin secretion in one study (Lardinois et al, 1987) and a reduction in another 
(Glauberr et al, 1988; Panzram, 1987) again this is consistent with the intermediate 
influence of the com oil diets in these studies. However in subjects given fish-oil 
(Fasching et al, 1991), no changes were observed in either fasting concentrations of 
insulin or concentrations after glucose loading calculated as incremental area under 
the curve.
In previous animal studies fish oil decreased the hyperinsulinemia of a high 
sucrose model (Behme et al, 1993). However in another insulin-resistant mouse 
model, the gold thioglucose-induced non-insulin-dependent diabetic mice, fish oil 
supplementation did not correct either hyperglycemia or hyperinsulinemia (Chen et 
al, 1991). Recently Chicco et al, (1996) concluded that, the administration of low 
doses of fish oil to normal Wistar rats is accompanied by a significant reduction of
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plasma insulin levels without changes in glucose tolerance, and that this may be the 
result of increased peripheral insulin sensitivity in normoglycemic animals. Similar 
results have been reported in pig studies by Behme, (1996): i.e. n-3 PUFA 
significantly increases the insulin sensitivity compared to n-6 PUFA without 
changing the glucose disappearance rate. Through a clinical trial, Rivellese et al,
(1996) suggested that a low dose (2.7g/day) of n-3 PUFA for 6-months was not 
able to improve the insulin sensitivity in NIDDM patients. These different results 
in relation of insulinemia could be explained by differences in species, different 
insulin-resistant dietary models, and different doses and duration’s of fish oil 
supplementation.
Dietary fa t and insulin sensitivity:
With glucose tolerance a function of the amount of insulin secretion and the 
sensitivity of glucose transport to insulin the current results allow the mechanisms 
of the impaired glucose tolerance with the SFA to be explained. Table 4.2 shows 
the insulin sensitivity calculated as k-value/AUCxlO^) in experiments II,III.
It is clear that with an increased insulin level and a reduced glucose disposal 
rate insulin sensitivity of the butter oil-fed animals was markedly impaired at either 
10% or 20% fat. Surprisingly, 10% com oil feeding also impaired sensitivity 
compared with olive oil or fish oil or with the chow-fed controls in experiment III. 
The greatest impairment was observed with the 20% butter oil feeding where the 
group exhibited less than half the insulin sensitivity of all other groups with no 
difference between them. This clearly identifies SFA as detrimental to insulin 
sensitivity an effect which can be reversed by fish oil.
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Table 4.2 Insulin sensitivity: experiments II,HI.
Groups
Insulin sensitivity 
(k-value/ 
AUCxlO^)
Insulin
sensitivity
(k-value/
AUCxlO")
Dietary fat level Experiment I I 10% Experiment III 20%
4.25“
Control ±
(Rat chow) 0.37
2.98“ 4 .77“
Corn oil ± ±
0.56 0.36
4.03" 4 .90“
Olive oil ± ±
0.70 0.30
2.49 2.07
Butter oil ± ±
0.61 0.15
Fish oil/olive oil 1:1 Fish oil/olive oil 1:1
4.41“’" 4.91 “
Fish oil/olive oil ± ±
1.49 0.19
Fish oil/butter oil 1:1
Fish oil/butter oil 4 .36“
±
0.16
Statistical significance was determined by one-way ANOVA and Duncan’s test where 
P<0.05. Six rats were used in each group.
Experiments I & II. ‘a’ com oil, ‘b’ olive oil, ‘c’ butter oil and ‘d’ fish oil/olive oil 
Experiment III. ‘a’ rat chow, ‘b’ com oil, ‘c’ olive oil, ‘d’ butter oil, ‘e’ fish oil/olive oil and 
T  fish oil/butter oil.
Current dietary recommendation for diabetic subjects prescribe a reduction of 
total fat, saturated fat in particular, which should be replaced by carbohydrate 
(American Diabetes Association, 1987). However, monounsaturated fat may also be 
used as an alternative to saturated fat. Thus, clinical studies with high-fat diets rich in 
MUFAs showed improved lipoprotein composition in normal subjects (Mensink et al, 
1989; Grundy et al, 1986), improved glycémie control (Garg et al, 1988; Rasmussen 
et al, 1993), and lowered 24h ambulatory blood pressure in subjects with NIDDM 
(Rasmussen et al, 1993), compared with the recommended high-carbohydrate diet.
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This is consistent with the results here and in contrast to other rat studies recently 
reported by Picinato et al, (1998) involving an in vitro rat study showing that olive oil 
feeding increased the insulin secretion and glucose oxidation in pancreatic islets. 
Thus the current results show that a high MUFA diet in the rat maintains a relatively 
low insulinemia at the same level if  not somewhat better than in the chow fed control 
rats.
Dietary fats and membrane fatty acids:
The hypothesis examined in the present study included an expectation that 
dietary fat would influence glucose tolerance in part through alterations in membrane 
function as the result of altered phospholipid fatty acid concentration. The nature of 
the fatty acids within the phospholipid bilayer determines the physiochemical 
properties of membrane which in turn would be expected to influence cellular 
functions, including transport phenomena and hormone responsiveness (Field et al,
1988). In these studies membrane fatty acid composition was measured only in 
experiment I and III with reliable glucose tolerance and insulin sensitivity data 
collected only in the latter experiment. For this reason the fatty acid profiles measured 
in experiment III (tables 3:19, and 3:20) are reproduced here as the fatty acid profiles 
(Fig 4:2) and the ratios of the fatty acid classes (Fig 4:3).
Because measurements were made on pooled samples from each study it was 
not possible to conduct statistical analysis the overall profiles shown here were very 
similar to those obtained in experiment I (table 3:5) and between hepatic and red cell 
membranes. Furthermore the profiles reflected the dietary fat sources, in terms of the
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relative amounts of total SFA (highest in butter oil group) MUFA (highest in olive oil 
group), n6 PUFA (highest in com oil group and n-3 long chain PUFA (highest in fish 
oil group). Incorporation of long chain n-3 PUFA into fish-oil diet-fed rat liver 
membranes, in the present study, is in line with previous reports of Williams and 
Maunder (1992) and Hagve and Christophersen (1991).
Fig 4:2 Membrane phospholipid fatty acid profiles.
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Figure 4:3 Ratios of the fatty acid classes.
The way that fatty acids can influence membrane and cellular function can 
involve several different mechanisms (Tappia and Grimble, 1994) but two important 
ones are through the balance of precursors for eicosanoid production and through 
altering membrane fluidity. As would be expected eicosapentaenoic acid (C20:5, n-3, 
EPA) and docosahexaeneoic acid (C22:6 n-3) levels were elevated only in fish oil diet 
fed group. Similar results have been reported in earlier studies (Sirtori et al, 1992;
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Jones et al, 1995; Stinson et al, 1991) and in the adipocytes membrane phospholipids 
of fish oil fed rats (Luo et al, 1996). This demonstrates the n-6 to n-3 ratio in the diet 
does influence the ratio in the membrane fatty acid profile thereby affecting their role 
in mediating the metabolic responses to a wide range of insults including tissue injury 
or infection.
Eicosanoid production involves conversion of either the n-6 (AA, arachidonic 
acid) or n-3 (mainly EPA) precursors into eicosanoids which differ in relative activity. 
It is immediately apparent that the balance between AA and EPA in the various 
dietary groups could not have accounted for the variation in glucose tolerance or 
insulinemia. Firstly there is clearly no relationship between the overall n-6/n-3 ratio 
and glucose tolerance with the ratio very low in butter and fish oil and very high in 
olive oil and com oil and with chow intermediate. Secondly EPA was only detectable 
in the fish oil groups so that both butter and olive oil could only make n-6 eicosanoids 
yet differed markedly in their glucose tolerance. Indeed the AA content was highest in 
the olive oil (and chow) group. The presence of higher AA than linoleic (LA) acid 
levels in the olive oil fed group membranes compared to com oil fed rats has been 
explained as a favourable influence of dietary olive oil on the conversion of linoleate 
to arachidonate in liver microsomes (Periago et al, 1988). Thus the higher levels of 
AA in the olive oil and to a lesser extent in the butter oil groups and compared with 
the relatively low level of LA could possibly be attributed to the competition that 
exists among oleic, linoleic and linolenic acids for the delta 6 desaturase enzyme 
system. This enzyme system has the highest affinity for oleic acid followed by 
linoleic acid for elongation and desaturation of long chain PUFA (Periago et al, 
1990).
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As for membrane fluidity on the basis of the polyunsaturated to saturated fatty 
acid ratio in both liver or erythrocyte membrane lipids, it might be suggested that 
there was least membrane fluidity in butter oil group and the highest in fish oil fed rat 
membranes. However fluidity is a complex function of membrane composition since 
it can be influenced by chain length, the degree of unsaturation, the n6:n3 ratio and 
the amount of cholesterol (Tappia and Grimble, 1994). Indeed they report that in rats 
fed chow, butter, olive oil com oil and fish oil, membrane fluidity was lowest with 
com oil and highest with fish oil after 4 weeks but at 8 weeks fluidity fell markedly in 
the fish oil group to similar levels as the com oil group which they argue reflects an 
adaptation through increasing cholesterol in the fish oil group. If this is the tme then it 
becomes difficult to predict how fatty acid content might influence membrane 
fluidity. Nevertheless it is clear that the main characteristic of the profile reported here 
which correlates with glucose tolerance is the total saturated fat content. Indeed this 
was the only measure which corresponds with glucose tolerance i.e. similar values for 
all groups except for butter. While it is tempting to suggest that this difference 
mediated its influence through membrane fluidity since this was not measured and 
given the complexity of the relationship as identified by Tappia and Grimble, (1994) 
further studies will be required to identify the actual mechanism.
In conclusion: the results of the present studies provide evidence that
replacing saturated fats with monounsaturated or polyunsaturated fats are most 
beneficial. Even though MUFA increases body fat and weight, it does not impair 
glucose intolerance or insulin sensitivity, n-3 PUFA has been shown to control fat 
accumulation and prevent obesity when it is combined with either MUFA or SFA.
1 0 8
Furthermore these combinations have a markedly beneficial effect on glucose 
intolerance and on insulin sensitivity. Further work will be necessary to evaluate the 
mechanisms of these effects.
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CONCLUSION
This thesis describes work aimed at demonstrating and resolving the 
importance of dietary fat quality on glucose tolerance and insulin sensitivity. This has 
been achieved by the clear demonstration that in this rat model with relatively high fat 
diets (20% w/w, 40% energy) in which butter, com oil, olive oil and fish oil are fed as 
representative of the major dietary fatty acid classes (SFA, n-6 PUFA, MUFA and n-3 
PUFA), only the high SFA diet as butter impairs glucose tolerance or insulin 
sensitivity. No clear differences were observed between MUFA or the two PUFA fat 
sources although it was clear that MUFA was at least as good as the PUFA diets. 
Furthermore it was also clear from the membrane lipid profiles that wide differences 
in the n6:n3 PUFA/MUFA ratios were unrelated to glucose tolerance or insulin 
sensitivity, with only total SFA correlating with these measures. Further work is 
required to establish what properties of membrane function were influenced by this 
increased total SFA.
While these results clearly demonstrate the safety of both high MUFA and 
PUFA diets for maintaining glucose tolerance the increased fatness observed with the 
MUFA as well as SFA diets raise important concems about MUFA. The further 
examination of the nature of these changes in fatness with MUFA and SFA, not 
observed with the PUFA diets is an obvious area for future work. Given the concem 
for reducing the n6-n3 ratio in the diet to reduce inflammatory processes it would 
appear that out of the fats studied here fish oil appears to be associated with the most 
wide ranging benefit.
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APPENDIX. Analytical Procedures
Method
Werner, W. et al. (1970). Z. analyt. Chem. 252:224 
DPD 1648840 and other foreign patents
Test principle 
Glucose + 
complex + H^O
■> gluconate + H2 O2  / H2 O2  + ABTS®^°° > colored
Contents of kit M PR2 M PR3 Preparation and stability of solutions
Bottle 1
Standard 1 X 10 ml 1 X 30 ml
Use contents as supplied.
Stable up to specified expiration date
0
when stored at + 15 to 25 C
Bottle 2
Buffer/ enzymes/c 
hromogen
2 bottles for 
2 X 300 ml
3 bottles for 
3 X 1000 ml
M P R 1: Dissolve contents of one bottle 2 
in
300 ml dist. water 
MPR 2: Dissolve contents of one bottle 
2
in 1000 ml dist. water 
Store in amber glass bottles!
Stable for 6 weeks at +2 to 8°C
Sample preparation
Blood: Deproteinize immediately!
Serum or plasma should be separated from cellular constituents immediately if 
possible, and no later than one hour after collecting the blood specimen. The 
sample can be stored up to 24 hours at +15 to 25°C after addition of a glycolysis 
inhibitor (NaF, KF)^, or up to 7 days in a closed vessel at +4°C.
Reference: Hoffmeister, H. and B. Junge. (1970) (Z. Klin. Chem. Klin. Biochem. 
8:613
Pipette into a centrifuge tube:
URAC®
Sample
1.00 ml 
0.10 ml
Flush the pipette with the mixture severa 
Centrifuge the suspension, and use 0.10 c 
the supernatant for the assay.
times.
»r 0.20 ml of
The decanted supernatant can be stored up to 3 days in a closed vessel at +4°C.
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Procedure
Wavelength: Hg 436 nm or Hg 578 run 
Spectrophotometer: 610 nm 
Cuvette: 1 cm light path 
Incubation temperature: 20-25°C 
Measure against blank.
One blank and one standard are sufficient for each assay series.
For measurement at Hg 436 nm
Pipette into test tubes:
dist. water 
solution 1
deproteinized supernatant 
solution 2
blank
0.1 ml
5.0 ml
standard
0,1 ml 
5.0 ml
sample
0.1 ml 
5.0 ml
For measurement at Hg 578 nm or 560-620 nm
Pipette into test tubes:
blank standard sample
dist. water 
solution 1
deproteinized supernatant 
solution 2
0.2 ml
5.0 ml
0.2 ml 
5.0 ml
0.2 ml 
5.0 ml
Mix and incubate at 20-25°C. Avoid exposure to direct sunlight. 
After 25-50 min, measure the absorbances of the sample (A )
sample
and standard (A ) against the blank.
__________________________ sample______________________________________________________________________
Couceutratiou of solutiou 1
Glucose: 9.1 mg/dl (0.505 mmol/1)
Couceutratious of solutiou 2
POD ^  0.35 U/ml; GOD ^  8 U/ml; ABTS®, : 1.0 mg/ml 
Calculatiou
of the concentration (c) of glucose in blood, serum or plasma:
A  sample
c = 100 X ----------  [mg/dl] or
A
standard
A  sample
c = 5.55 X ----------  [mmol/L]
A
standard
130
Determination o f Insulin Couceutratious:
* Euzymuu-Test® Insulin (ALISA)
ELlSA-principle (enzyme-linked immunosorbent assay)
Immuuodiaguostics 
Boehriuger Mannheim
Enzyme-immunological test for the quantitative determination of insulin in vitro
Cat. No. 199 648 for 100 tests 
Test principle
In the first incubation step, the serum insulin is bound by the insulin antibodies 
coated onto the inside wall of the test-tube.
In the second incubation step, POD-labeled insulin (soln. 3a) occupies the 
remaining free binding sites on the antibodies (sequential saturation).
The amount of antibody-insulin-POD complex formed is a measure of the insulin 
content of the sample. The insulin-POD conjugate not bound by the antibodies is 
removed in a “bound/free” separation step.
In the third incubation step (indicator reaction, soln.5a), the addition of substrate 
and a chromogen (ABTS®) results in formation of a dye, the absorbance of which 
is proportional to the enzyme activity of the antibody-insulin POD caps complex 
bound to the tube wall. The colour intensity that develops within a predetermined 
time is measured against the substrate/buffer solution (5a), which serves as a 
blank.
It follows from the competition principle that increasing serum insulin 
concentrations in the sample will result in less insulin-POD conjugate-binding by 
the antibodies and hence in lower measured enzyme activities.
The results are obtained from a calibration curve that must be set up by the 
investigator using the standards provided in the kit.
Contents of the kit:
1. Buffer for incubation 
(colour code blue) 
phosphate buffer
2. Insulin-POD conjugate 
(colour code red; x2)
POD
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3. Conj ugate/buffer 
(colour code red) 
phosphate buffer bovine serum
albumin
(BSA)
4. Substrate
(colour code green) •
ABTS®*
5. Substrate/buffer 
(color code green) 
phosphate.citrate buffer 
sodium perborate
6 (a-e)Standards 
(colour code yellow) 
insulin in human serum
7. Control serum 
(colour code brown) 
insulin in human serum
Preparation and stability of solutions
1. Dissolve contents in 105 ml redist. water (see Note 1). Stable for three months 
at +2 to 8°C.
2. Dissolve contents of each vial in 0.6 ml redist. water and use to prepare solution 
3a (see Note 1). Stable for four weeks at +2 to 8°C or up to the expiry date 
specified when stored at -20°C. The solution may be thawed and reffozen 
repeatedly.
3&5 The solution is ready for use (Note 1). Stable up to the printed expiry date 
when store at +2 to 8°C.
4. Transfer contents to bottle 5 to prepare solution 5a.
Working solutions, standards, control serum. 
3a Conjugate solution
Prepare the daily requirement by mixing one part by volume of solution 2 into
100 parts by volume of solution 3 at least 1 h before starting determinations.
1 ml of the solution so prepared (solution 3a) is required per tube of standard,
control serum or sample (multiple assays). (See Note 1).
Avoid the formation of foam when mixing.
Do not freeze the solution!
Store protected from light.
Bring to+20 to 25°C before use. Stable for 24 hours at +2 to 8°C.
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5a Substrate/Buffer
Add the contents of vial 4 to solution 5 at least 1 hour before commencing 
determinations and dissolve the substances completely. Bring to+20 to 25°C 
before use. Stable for three months at +2 to 8°C.
6a- Standards/control serum
6e Carefully add 1.5 ml of redist. water to each vial and let stand closed for 15 7 
min to reconstitute. Mix carefully to ensure the homogeneity of the 
solutions. Stable for six hours at +20 to 25°C
four days at +2 to 8°C 
six months at -20°C.
Freeze unused solutions immediately at -20°C. This may be done twice, or at 
most three times (see Note 2). Bring solutions to +20 to 25°C before use.
Storage and stability of tubes
Take the required number of tubes out of the tube box just prior to starting the 
test, and immediately transfer the unused tubes in the stand and the desiccant 
capsules to the polyethylene bag. Close the bag properly to avoid premature 
exhaustion of the desiccant.
Occasionally a white coating may form on the inside of the tubes; this has no 
effect on the determination.
Stable up to the ecpiry date specified when stored at +2 to 8°C.
Procedure
Wavelength; Hg 405 nm (see Note 3)
Spectrophotometer: 420 nm (see Note 3)
Semimicro cuvette: 1 cm light path (see Note 4)
Incubation temperature: +2 to 8°C or +20 to 25°C (see Note 5)
Measure against solution 5a (+20 to 25°C).
Construct a new calibration curve for each assay series. Duplicate 
determinations are recommended for both samples and standards.
Reagents and antibody-coated tubes from different kits having the same lot 
number can be pooled. Carry out successive pipetting steps as rapidly as possible 
(see Note 6). Add solution 1 rapidly or mix thoroughly with the sample material.
Evaluation
Construction o f calibration curve
Plot the mean absorbances A against the respective concentrations of the standards 
on graph paper.
Abscissa (x-axis): pU insulin/ml 
Ordinate (y-axis):A
Draw the calibration curve through the points.
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Determination o f sample insulin concentration
Obtain the insulin concentrations of the samples from the calibration curve by 
reading off against the respective value of A.
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* Insulin (Radioimmunoassay)
Coat-A-Count®
INSULIN
Principle of the Procedure
In the Coat-a-Count Insulin procedure, ^^^I-labeled insulin in the patient sample 
for sites on insulin-specific antibody immobilized to the wall of a polypropylene 
tube. After incubation, isolation of the antibody-bound fraction is achieved 
simply by decanting the supernatant. The tube is then counted in a gamma 
counter, the counts being inversely related to the amount of insulin present in the 
patient sample. The quantity of insulin in the sample is then determined by 
comparing the counts to a standard curve.
Procedure There is only one reagent to dispense, and a single overnight
(or 3-hour) incubation. No centrifuge is required. The 
simplicity of the Coat-A-Count procedure makes it ideal for 
high-volume testing.
Separation The coated-tube methodology offers significant advantages 
in reliability, since the tubes can be vigorously decanted 
without loss of antibody-bound material. This results in a 
clean separation, with negligible misclassification of bound 
and free.
Data reduction
Calibration
Counts
Conventional RIA techniques of calculation and quality 
control are applicable. The assay has been optimized for 
linearity in a logit-log representation throughout the range of 
its calibrators. The computation can be simplified by 
omitting the correction for nonspecific bonding, without 
compromising results or quality control.
The calibrators have been prepared in processed human 
serum, to insure full compatibility with patient serum 
samples. This approach offers significant advantages, 
particularly with respect to interlaboratory precision 10. 
The calibrators, which are supplied lyophilized for 
maximum stability, have insulin values ranging from 5 to 
400 pIU/mL. The assay is standardized in terms of the 
World Health Organization’s First International Reference 
Preparation of Insulin of Immunoassay, number 66/304.
The tracer has a high specific activity with total counts of 
approximately 45,000 cpm at iodination. Maximum binding 
is approximately 50%.
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Accuracy Extensive experiments have shown that the assay is accurate 
over a broad range of insulin values. Its accuracy has been 
further verified in a patient comparison study against 
another insulin radioimmunoassay.
Specificity The antiserum is highly specific for insulin, with very low 
crosseactivity to other compounds that might be present in 
patient samples. Crossactivity with pro-insulin at mid-curve 
is approximately 40%. The freedom from “matrix effects” 
is demonstrated by patient sample dilution experiments and 
by studies on the effect of bilirubin and lipemia.
Sensitivity The procedure can detect as little as 1.2 pIU/mL using the 
overnight procedure, or 1.5 pIU/mL using the same-day 
procedure.
Radioimmunoassay Procedure
All components must be at room temperature before use. 
recommended for this assay.
An automatic pipetter-diluter is not
1. Plain tubes: Label four {plain (uncoated) 12x75 mm polypropyllene tubes 
T(total counts) and NSB (nonspecific binding) in duplicate.
Because nonspecific binding in the Coat-A-Count is characteristically low, the NSB tubes may be safely omitted 
without compromising accuracy or quality control.
Coated Tubes: Label fourteen Insulin Ab-Coated Tubes A (maximum 
binding) and B through G in duplicate. Label additional antibody-coated 
tubes, also duplicate, for controls and patient samples.
Calibrators
lU/mL 
rU RP (66/304)
A(MB) 0
B* 5
C 15
D 50
E 100
F 200
G 40
*Omit calibrator B if the alternate, 3-hour, 37°C incubation will be used at step 4.
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2. Pipet 200 \iL  of the zero calibrator A into the NSB and A tubes, and 200 p,L 
of each remaining calibrator, control and patient sample into the tubes 
prepared. Pipet directly to the bottom.
3. Add 1.0 ml of ( I) Insulin to every tube. Vortex.
Samples should not be left in the tubes for extended periods of 
time. Following step 2 (sample addition), step 3 (tracer addition) 
should be completed with minimal delay, with no more than 40 
minutes elapsing between the addition of the first sample and the 
completion of tracer addition. Set the T tubes aside for counting 
(at step 6); they require no further processing.
4. Incubate for 18 -  24 hours at room temperature.
Alternatively, incubate for 3 hours at 370°C, using a waterbath -  
neither an oven nor a heat block is suitable - and omitting the 5 
pIU/mL calibrator) Calibrator B). This approach allows for same- 
day results at some sacrifice in low-end sensitivity and precession. 
(See the sensitivity table and precision profiles in the Performance 
Data section).
5. Decant thoroughly.
Removing all visible moisture will greatly enhance precision/using 
a foam decanting rack, decant the contents of all tubes (except the 
T tubes) and allow them to drain for 2 to 3 minutes. Then strike 
the tubes sharply on absorbant paper to shake off all droplets.
6. Count for 1 minute in a gamma counter
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Membrane Phospholipids Estimations:
^Hepatic membrane isolation
1. Remove liver 50 0.15M Saline. (All steps are done at 4°C). A portion of liver 
of approx. 1 g is placed in a conical tube to which 10ml of buffer A are added. 
Buffer A (150mM NaCl, 1 mN CaClz, 10 mM tris HCl At pH 7.5).
2. Livers are homogenized with 2-ten sec pluses of a Politron (Brinkmann 
Instumetnst, Westbury NY) at a setting of 10.
3. The homogenate is centrifuges for 5 min at 2,000 rpm in J2-21 centrifuge. 
The pellet is discarded.
4. The resulting supernatant is centrifuges at 8,000 rpm for 15 min and the pellet 
is discarded.
5. The supernatant is centrifuged at 38,000 rpm for 1 hr. in the untracentrifuge 
(Beckman Instruments, Palo Alto CA) at 4°C.
6. The pellet is resuspended in 6 ml of buffer A and flushed 10 times through a 
22-guage needle and ultracentrifugation is repeated for 1 additional hr at 
38,000 rpm.
7. The pellet is kept is cryule vials in liquid nitrogen to be used later in binding 
assays.
8. Before using for binding, pellets are resuspended in 500 pi of buffer A by 
flushing 10 times through a 22-gauge needle and protein is determined.
9. Hepatic membrane dilutions are prepared by taking a aliquot of the 
resuspended membranes and adding buffer B (lOOmM NaCl, 0.5 mM CaClj, 
50 nM tris-HCl, 20 mg/ml bovine serum albumin at pH 7.5).
10. Blood samples centrifuge at 8,000 rpm for 1 minutes.
11. 10 milliliter packed cells were washed 5 times with chilled lOmMole Triss- 
HCl buffer pH 7.4.
12. The isolation of erythrocytes membranes was carried out as described in above 
steps 1-9 (for hepatic membrane isolation).
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* Fatty acid extraction:
1. Stored liver membrane extract from above were centrifuges at 2500 prm for 
5min and supernatant discarded.
2. Chloroform : methanol (2:1) 2ml were added and taken into homogenizing 
tube.
3. Homogenized on (standard tissue homogenizer system-bead mill fitted with 
aqueous / organic coarse homogenizing probe, 3 pulses for 10 mins.
4. Centrifuges at 2500 prm for 10 min and clear supernatant stored in a labeled 
test-tube.
5. Steps 2-4 were repeated three times.
6. For 6 ml pooled supernatant Va, 2ml Of n-saline added and vortexed for 5 min.
7. Centrifuged at 2500 prm for 10 min and lower organic layer taken and stored 
in labeled tube.
8. Nitrogen gas blown over pooled organic extract to dryness and lipid extract 
saved for estérification.
"^Estérifications:
1. Extract taken with 10ml benzeneimethanol: conchs04 (10:84:4) and put in 
teflon coated screw pyrex glass tube.
2. Cap closed and put in water bath and heated at 80-90°C for 1 and Vi hours with 
occasional shaking.
3. Bottles colled and 15 ml distilled water added.
4. Extracted 3 times with hexane 5ml.
5. Hexane extract washed 3x with distilled water and extract in solvent hexane 
layer frozen for later Gas Chromatograph injection.
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Table 1 
Composition of mineral and vitamin mix.
Bernhart-Tomatelli salt mixture^
s/kg
Calcium carbonate 21.00
Calcium phosphate ICaHPOd) 735.00
Citric acid 227
Cunric citrate Vi H?0 0.46
Potassium diphosphate 81.00
Ferric citrate 5 H?0 5J8
Magnesium oxide 25.00
Manganese citrate 835
Potassium iodide 0.01
Potassium sulphate 6&00
Sodium chloride 30.60
Disodium phosphate 21.40
Zinc citrate 2H?0 1.33
Vitamin mix2 (in dextrose)
g/kg
Vitamin A concentrate (200.000 units/gl 4.50
Vitamin D concentrate (400,000 units/gl 0.25
Alpha-tocopherol 5.00
Ascorbic acid 45.00
Inosital 5.00
Choline chloride 75.00
Menadione 225
Para-amino benzoic acid 5.00
Niacin 4.50
Riboflavin 1.00
Pvridoxine hvdrochloride 1.00
Thiamine hvdrochloride 1.00
Calcium pantothenate 3.00
mg/kg
Biotin 20.00
Folic acid 90.00
Vitamin B12 1.35
1. ICN Nutritional Biochemicals, Cleveland OH.
2. Special Diet Services, Witham Essex.
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Composition of Control Diet (Rat Chow)
Net Weight: 50K.G. LABORATORY ANIMAL DIET
Storage: In a dry place out of direct sunlight 
Declaration:
F.648
Crude Protein,% 20.00 Calcium,% 1.00
Crude Fat,% 4.00 Phosphorus,% 0.60
Crude Fiber,% 3.50 Vitamin A, lU/g 20.00
Ash,% 6.00 Vitamin D, lU/g 2.20
Salt 0.50 Vitamin E, lU/g 70.00
Energy, ME Kcal/kg 2850.00
Trace mineralls addec include:
Cobalt, Copper, Iodine, Iron, Manganese, Selenium and Zinc 
WARNING: Feed to Laborary Animal Only 
Manufacturing date:
Manufactured by: Grain Silos and Flour Mills Organization -  Riyadh Branch, 
Saudi Arabia
lAavuan Aaauns a o  A iisu a A iN n
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Reproduced with permission of copyright owner. Further reproduction prohibited without permission.
